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Abstract
HBO1 is a member of the human MYST family of acetyltransferases that is evolutionarily conserved from
yeast to human. HBO1 functions in the context of a multi-protein histone acetyltransferase (HAT) complex
containing JADE1/2/3, HBO1, ING4/5 and Eaf6 to regulate DNA replication, transcription, and other
important cellular processes. HBO1 is shown to be responsible for the majority of H4 acetylation
throughout the human genome. HBO1 functions in many important biological processes such as
interaction with the origin recognition complex (ORC) and loading of the minichromosome maintenance
protein complex (MCM), highlighting its importance in DNA replication. In addition, HBO1 is heavily colocalized to the transcription start site and H3K4me3 mark, which is one of the post translational
modifications (PTMs) recognized by the PHD domains of another subunit in the HBO1 HAT complex
containing HBO1, JADE, ING, Eaf. The activity of HBO1 is heavily dependent on the regulatory proteins
within the HBO1 HAT complex.
We demonstrate that the scaffold protein JADE functions as a platform to bring other subunits together
forming a stable HBO1 HAT complex in addition to recruiting the substrate. Importantly, JADE is the main
protein in the HBO1 HAT complex contributing to modulation of the activity and substrate specificity.
Based on the fact that JADE contributes strongly to the overall activity of the HBO1 HAT complex, we
dissected the molecular role of JADE in HBO1 histone acetyltransferase activity. We demonstrate that
JADE contains 2 domains at the N-terminal end of the protein that cooperate to activate HBO1 activity
towards H3/H4 substrate. Specifically, the Histone Core Biding Domain (HCBD) of JADE1 binds to the
core of the histone and HBO1 and the Histone Binding Domain (HHBD) binds to both the HAT domain and
the histone core, orienting the HAT domain towards the substrate. In addition, we demonstrated that
JADE specifically binds to H3/H4 over H2A/H2B histones suggesting that the substrate recruitment is
through specific interaction between JADE and H3/H4 rather than non-specific charge interaction. We
demonstrate that HBO1 contains an N-terminal Histone Binding Domain (HBD) that makes additional
contacts to H3/H4, independent of JADE interactions with histones. However, the additional HBO1
binding domain does not contribute to the overall HAT activity. Together, these studies highlight the
importance JADE in HBO1 function.
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ABSTRACT

Joseph Han

Ronen Marmorstein

HBO1 is a member of the human MYST family of acetyltransferases that is evolutionarily
conserved from yeast to human. HBO1 functions in the context of a multi-protein histone
acetyltransferase (HAT) complex containing JADE1/2/3, HBO1, ING4/5 and Eaf6 to regulate DNA
replication, transcription, and other important cellular processes. HBO1 is shown to be
responsible for the majority of H4 acetylation throughout the human genome. HBO1 functions in
many important biological processes such as interaction with the origin recognition complex
(ORC) and loading of the minichromosome maintenance protein complex (MCM), highlighting its
importance in DNA replication. In addition, HBO1 is heavily co-localized to the transcription start
site and H3K4me3 mark, which is one of the post translational modifications (PTMs) recognized
by the PHD domains of another subunit in the HBO1 HAT complex containing HBO1, JADE, ING,
Eaf. The activity of HBO1 is heavily dependent on the regulatory proteins within the HBO1 HAT
complex.

We demonstrate that the scaffold protein JADE functions as a platform to bring other
subunits together forming a stable HBO1 HAT complex in addition to recruiting the substrate.
Importantly, JADE is the main protein in the HBO1 HAT complex contributing to modulation of the
activity and substrate specificity. Based on the fact that JADE contributes strongly to the overall
activity of the HBO1 HAT complex, we dissected the molecular role of JADE in HBO1 histone
acetyltransferase activity. We demonstrate that JADE contains 2 domains at the N-terminal end
of the protein that cooperate to activate HBO1 activity towards H3/H4 substrate. Specifically, the
Histone Core Biding Domain (HCBD) of JADE1 binds to the core of the histone and HBO1 and
the Histone Binding Domain (HHBD) binds to both the HAT domain and the histone core,
orienting the HAT domain towards the substrate. In addition, we demonstrated that JADE
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specifically binds to H3/H4 over H2A/H2B histones suggesting that the substrate recruitment is
through specific interaction between JADE and H3/H4 rather than non-specific charge interaction.
We demonstrate that HBO1 contains an N-terminal Histone Binding Domain (HBD) that makes
additional contacts to H3/H4, independent of JADE interactions with histones. However, the
additional HBO1 binding domain does not contribute to the overall HAT activity. Together, these
studies highlight the importance JADE in HBO1 function.

vi

Table of Contents

Table of Contents

Acknowledgements ............................................................................................................................. iii
Abstract ...................................................................................................................................................... v
Table of Contents ................................................................................................................................vii
List of Figures .......................................................................................................................................... x
1.1 Histone Acetylation .................................................................................................................. 2
1.2 HBO1 Histone Acetyltransferase (HAT) Complex .................................................... 6
1.3 Role of auxiliary subunits within histone acetyltransferase complexes ....... 12
1.4 Dissertation objective ........................................................................................................... 16
Chapter 2- Scaffold protein JADE is important for assembly and activity of the
HBO1 HAT complex .......................................................................................................................... 17
2.1 Abstract ...................................................................................................................................... 18
2.2 Introduction ............................................................................................................................... 19
2.3 Results ........................................................................................................................................ 22
2.3.1 JADE functions as a scaffold protein to bring other subunits together to
form different HBO1 HAT complexes .............................................................................. 22
2.3.2 Comparison of the Kinetic parameters of the 2-protein and 4-protein
HBO1 complexes indicates that JADE is sufficient for maximal HBO1 activity
........................................................................................................................................................... 25
2.3.3 The N-terminal Domain I of JADE forms a stable complex with the
HBO1 HAT domain. ................................................................................................................. 27
2.3.4 Domain I of JADE is sufficient for activation of HBO1 acetyltransferase
activity towards H4 peptide .................................................................................................. 37
2.4 Discussion ................................................................................................................................. 41
2.5 Materials and Methods: ...................................................................................................... 41
2.5.1 Full-length HBO1 HAT complexes ........................................................................ 41
2.5.2 Suprose-6 size exclusion chromatography. ..................................................... 42
2.5.3 JADE1/2/3 N-terminal sequence alignment ..................................................... 42
2.5.4 Recombinant HBO1 and JADE1 protein production in bacteria ............. 42
2.5.5 Histone acetyltransferase(HAT) activity assay ............................................... 43
Chapter 3 -The scaffolding protein JADE1 physically links the acetyltransferase
subunit HBO1 with its histone H3/H4 substrate ................................................................... 44
vii

3.1 Abstract ...................................................................................................................................... 45
3.2 Introduction ............................................................................................................................... 45
3.3 Results ........................................................................................................................................ 47
3.3.1 A 21-residue segment of JADE1 directly contacts the HBO1 HAT
domain and histone substrate to facilitate acetylation of free histones........... 49
3.3.2 JADE1 contains a second histone binding domain that contributes to
HBO1 acetylation of histone H4 substrate by anchoring the HBO1/JADE1
complex to the histone core................................................................................................. 53
3.3.3 JADE1-HCBD shows selectively for free histone H3/H4 over H2A/H2B
and nucleosomes ...................................................................................................................... 57
3.3.4 JADE1-HHBD and JADE1-HCBD bind independently to their
respective partners, but cooperate to potentiate HBO1-HAT acetylation ...... 60
3.3.5 HBO1 contains a region N-terminal to the HAT domain that binds
H3/H4 independent of JADE1 binding to H3/H4 ........................................................ 62
3.3.6 HBO1 may contain an auto-inhibitory domain ................................................ 65
3.3.7 Cellular experiments with JADE1 deletions recapitulate the role of
JADE1 in histone and HBO1 interactions and HBO1 acetyltransferase
activity............................................................................................................................................. 67
3.4 Discussion ................................................................................................................................. 69
3.5 Materials and Methods ........................................................................................................ 73
3.5.1 JADE1/2/3 N-terminal sequence alignment ..................................................... 73
3.5.2 Recombinant HBO1 and JADE1 protein production .................................... 73
3.5.4 Histone and nucleosome core particle production ........................................ 74
3.5.5 Pull down assay (GST-/MBP-) ................................................................................ 74
3.5.6 Histone acetyltransferase(HAT) activity assay ............................................... 75
3.5.7 JADE1-HBO1 complexes cotransfection in 293T cells ............................... 75
3.5.8 Immunoblotting............................................................................................................... 76
3.5.9 HAT activity assays on purified JADE1 complexes ...................................... 76
Chapter 4 -Conclusion and Future direction.......................................................................... 77
4.1 Overview .................................................................................................................................... 78
4.2 JADE as the scaffold protein for the HBO1 HAT complex ................................. 78
4.3 Kinetic approach to understanding the possible allosteric affects of JADE1
on HBO1 HAT domain................................................................................................................. 79
4.4 H3/H4 core chemical acetylation.................................................................................... 80
4.5 Purification of the HBO-HAT holo complex. .............................................................. 80
viii

Appendix A -Biochemical studies on the Nat10 acetyltransferase ............................. 82
A.1 Abstract ...................................................................................................................................... 83
A.2 Introduction............................................................................................................................... 83
A.3 Result .......................................................................................................................................... 85
A.4 Discussion ................................................................................................................................ 91
A.5 Materials and Methods ....................................................................................................... 94
A.5.1 NAT10 orthologs sequence alignment ............................................................... 94
A.5.2 Recombinant NAT10 protein production ........................................................... 94
A.5.3 Tubulin Purification ...................................................................................................... 94
A.5.4 NAT10 Acetylation assays ....................................................................................... 95

ix

List of Figures

Figure1. 1 Table of different members of the human histoneaceyltransferases
(HATs). ........................................................................................................................................................ 3
Figure1. 2 Acetylation and regulation of histoneacetylation................................................. 5
Figure1. 5 Common features of the MYST histone acetyltransferase (HAT)
complexes. .............................................................................................................................................. 10
Figure1. 6Model for alternate MSYT acetyltransferase assembly leading to different
substrate specificities......................................................................................................................... 11
Figure1. 7X-Ray crystallographic structures of histone acetyltransferase (HAT)
complex.................................................................................................................................................... 15
Figure 2. 1The schematic representation of 2 different HBO1 HAT complex
formation due to splice variants on JADE .................................................................................. 21
Figure 2. 2JADE functions as a scaffold protein to assemble different HBO1 HAT
complex.................................................................................................................................................... 24
Figure 2. 3 JADE is the main player of the HBO1 HAT complex in catalytic
contribution. .......................................................................................................................................... 26
Figure 2. 4 Primary sequence alignment of JADE1/2/3/ Paralogs. ................................. 28
Figure 2. 5 Primary sequence alignment of HBO1 and its orthologs from various
species all the way from yeast to human. ................................................................................... 30
Figure 2. 6JADE domain I forms a complex with HBO1 HAT domain. ............................ 32
Figure 2. 7JADE1 projects the N-terminal end of HBO1 HAT domain. ........................... 34
Figure 2. 8HBO1 is hydrolyzed at the flexible region in the HAT domain ..................... 36
Figure 2. 9HBO1 HAT domain responses to addition of JADE Domain I in
acetyltransferase activity ................................................................................................................. 38
Figure 2. 10JADE1 Domain I (1-188) is able to stimulate activity of the isolated
HBO1 HAT domain towards H4 peptides ................................................................................... 40
Figure 3. 1HBO1 acetyltransferase activity on different histone substrates................ 48
Figure 3. 2An N-terminal region of JADE1 binds HBO1. ....................................................... 51
Figure 3. 3JADE1 requires an additional N-terminal region for H3/H4 binding and
HBO1 HAT potentiation. ................................................................................................................... 53
Figure 3. 4The additional JADE1 N-terminal HCBD specifically binds the histone core
region........................................................................................................................................................ 56
Figure 3. 5JADE1 selectively binds to H3/H4 over H2A/H2B and the nucleosome
core particle. .......................................................................................................................................... 59
Figure 3. 7HBO1-FL contains an N-terminal H3/H4 binding domain that binds
histones independently of JADE1. ................................................................................................. 64
Figure 3. 8Activity comparison of HBO1 full length vs HBO1 HAT domain.................. 66
Figure 3. 9JADE1 HHBD and HCBD are both required for HBO1 acetyltransferase
activity on histones in cells. ............................................................................................................. 68
Figure 3. 10Schematic of the HBO1, JADE1, H3/H4 complex based on the data
obtained in this study......................................................................................................................... 72
Figure A. 1 NAT10 ............................................................................................................................... 86
Figure A. 2 Purification of NAT10 acetyltransferase domain ............................................. 87
x

Figure A. 3 ITC of NAT10(494-753) with A-CoA, Acetonyl-CoA, CoA, Remodelin ..... 89
Figure A. 5 Radioactive assay of NAT10 acetyltransferase activity. ................................ 92
Figure A. 6Radioactive assay of NAT10 acetyltransferase activity. ................................. 93

xi

Chapter 1 - Histone tail modifications and the important players

Section 1.3 excerpt was taken from a review in preparation for submission to Protein Science.
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1.1 Histone Acetylation

Eukaryotic nucleosomes, comprised of two copies each of H2A, H2B, H3, and H4, are
assembled into an octomer, which is wrapped in ~150 basepairs of DNA. The chain of these
repeating units of assembled nucleosomes are subjected to different post translational
modifications (PMTs) that aid in conformational switching between euchromatin and
heterochromatin leading to either gene expression or repression respectively(Kornberg, 1974).
Histone

post

translational

modifications

(PTM)

such

as

acetylation,

phosphorylation,

SUMOylation, ubiquitination, and methylation introduce new functional groups to different histone
proteins at specific residues. Together, different histone modifications have been shown to work
through a combinatorial effect (referred to as the histone codes (Strahl and Allis, 2000)) that
function in various cellular signaling events to carry out DNA-templated biological processes in
response to external or internal signals (Drazic and Winter, 2014; Verdin and Ott, 2015). More
than 50 years ago, Allfrey and coworkers first discovered that histones are acetylated to mediate
gene transcription (Allfrey and Mirsky, 1964), but it was not until about 30 years later that Allis
and coworkers isolated the first histone acetyltransferase (HAT) enzyme (Brownell et al., 1996).
Since the discovery of the first HAT, acetylation has been one of the most extensively studied
PTMs, leading to the discovery of more than 20 HATs (Drazic et al., 2016) (Figure1.1).
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Figure1. 1 Table of different members of the human histoneaceyltransferases (HATs).

The list shows their names, localizations, and substrates

Drazic et al. (2016) Biochim Biophys Acta.
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Histone acetylation, a covalent modification on lysine residues within histone tails H2A,
H2B, H3 and H4, regulates local and global chromatin dynamics—thus playing an important role
in modulating gene expression in all living eukaryotic organisms. Generally, hyperacetylation and
hypoacetylation are observed in transcriptionally active and inactive regions of the chromatin,
respectively (Kornberg and Lorch, 1999; Sapountzi and Cote, 2011; Strahl and Allis, 2000; Struhl,
1998; Thomas and Voss, 2007). This post-translational modification on the amino group of lysine
side chains neutralizes the positive charge, which in turn leads to an alteration in structure of the
amino acid as well as the relative local hydrophobicity (Drazic et al., 2016; Sapountzi and Cote,
2011). This affects transcription in two major ways. First, the altered physiochemical properties of
the lysine residue on the histone tails are believed to directly participate in making chromatin
more accessible for gene activation by loosening up the interaction with the neighboring DNA
(Figure1.2A). Second, lysine acetylation generates docking recognition sites for various genemodulating proteins containing bromodomains or other acetyl-lysine recognition domains (Drazic
et al., 2016; Havasi et al., 2013; Jenuwein and Allis, 2001; Peterson and Laniel, 2004; Taverna et
al., 2007; Turner, 2000) (Figure1.2B,C). Histone acetylation is reversible and is mediated by
histone deacetylase (HDAC), whose activity is generally correlated with gene repression or
silencing (Allis et al., 2007). Together, the tight regulation of acetylation and deacetylation on
lysine residues within histones by HATs and HDACs is very important to maintain normal gene
expression. Due to the importance of HATs and HDACs in regulating gene expression, the
altered activity of these enzymes has been connected to various diseases such as cancer,
neurodegenerative diseases and cardiovascular disorders (Haberland et al., 2009a; Haberland et
al., 2009b; Saha and Pahan, 2006).
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Figure1. 2 Acetylation and regulation of histoneacetylation.

(A)This reversible histoneacetylation leads to conformational changes from heterochromatin to
the more open euchromatin structure. The reverse mechanism is done by Lysine deacetylases
(KDAC). (B) The acetylated Lysine is recognized by the bromodomain within a larger protein
complexes such as transcription factors(TFs) or chromatin remodeling complexes(CRCs) (C)
Transcriptional repression is regulated by specific repressors, recruiting histonedeacetylases
(HDACs). Drazic et al. (2016) Biochim Biophys Acta.

The addition of acetyl groups on histone tails is catalyzed by HATs are categorized into
different families based on sequence conservation, called Gcn5/PCAF, MYST, p300/CBP and
Rtt109 (Drazic et al., 2016) (Figure1.1). Each of the HAT families also contain structural
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homology, conserved catalytic properties, and specificity toward their respective cognate
substrate (Marmorstein and Zhou, 2014) (Figure1.3). Most importantly, HATs function as
members of multi-protein complexes where catalytic activation and substrate specificity can be
modulated by other subunits within the complex (Berndsen and Denu, 2008; Marmorstein and
Zhou, 2014).

1.2 HBO1 Histone Acetyltransferase (HAT) Complex

HBO1 (KAT7) is a member of the human MYST family of acetyltransferases that is
evolutionarily conserved from yeast to human. The name MYST (Moz, YBF2, Sas2p, Tip) is
derived from the founding members of this acetyltransferase family. The MYST family of
acetyltransferases is characterized by a highly conserved MYST domain, and is further
distinguished into three different subgroups depending on the domain compositions outside of the
catalytic domain(Thomas and Voss, 2007) (Figure 1.4). Other members of the human MYST
family include TIP60(KAT5), MOZ(KAT6A), MORF(KAT6B), and MOF(KAT8). HBO1 is
responsible for the majority of H4 acetylation throughout the human genome, and directly
regulating DNA replication through this activity (Doyon et al., 2006; Foy et al., 2008; Miotto and
Struhl, 2010). The lethality of HBO1 knockout mice also suggests that HBO1 HAT activity is
required in modulating expression of key genes in development and embryonic patterning (Kueh
et al., 2011). Finally, the importance of HBO1 catalytic activity is highlighted by the findings that a
HBO1 catalytic defective mutant inhibits interaction with ORC (Iizuka and Stillman, 1999)and
loading of MCM complex onto the origin, indicating that the HBO1 HAT complex functions as a
DNA replication co-activator in addition to its other roles (Havasi et al., 2013; Miotto and Struhl,
2008, 2010). Smith and coworkers have observed over-expression of HBO1 in MCF7 and Saos-2
established cancer cell lines and in a subset of human primary cancers such as carcinomas of
testis, breast, and ovary (Iizuka et al., 2009).
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Figure1. 3 Over all structure of 5 HAT subfamilies illustrated as cartoons. (Blue)
structurally conserved core region (aqua) flanking N- and C- termini Cofactor shown as
stick figure.

(A)YeastHAT1/AcCoA (PDB:1BOB) (B)Tetrahymena Gcn5/CoA/histone H3 (PDB : 1PUA) with
the histone H3 peptide shown in red (C)Yeast Esa1/H4K16-CoA (PDB : 3TO6) (D)Human
p300/Lys-CoA (PDB : 3BIY) with the substrate-binding loop shown in red (E)Yeast Rtt109/CoA
(PDB : 3D35) with the substrate-binding loop shown in red. Marmorstein et al. (2014) Cold Spring
Harb Perspect Biol.
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Figure1. 4 Schematic diagram comparing MYST family proteins and their protein domains.

Each domains are indicated in different colors
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HBO1 functions in the context of two multi-protein histone acetyltransferase complexes
containing ING4/5, MEAF6 and paralogs JADE1/2/3 for targeting the H4 tail or BRPF1/2/3 for
H3K14 acetylation (Feng et al., 2016; Lalonde et al., 2013) (Figure 1.5). The activity and
substrate selectivity of HBO1 is dependent on the proteins within the HBO1 HAT complex, which
also have other functions in various cellular proliferation and tumor suppression pathways. For
example, JADE1 was initially identified as a protein partner of the von Hippel-Lindau tumor
suppressor to regulate cellular oxygen sensing(Zhou et al., 2002). A recent study demonstrated
that an HBO1 complex containing the BRPF1 protein in place of JADE1 has specificity toward H3
tail acetylation, rather than the H4 tail acetylation preferred by the JADE1 containing complex
(Figure 1.6). This suggests that JADE1 contributes specifically toward H4 tail acetylation by the
HBO1 complex(Avvakumov et al., 2012; Havasi et al., 2013; Lalonde et al., 2013). Another
member of the HBO1 complex, ING, is an inhibitor of growth protein responsible for growth
regulation in eukaryotic organisms.

9

Figure1. 5 Common features of the MYST histone acetyltransferase (HAT) complexes.

Avvakumov et al. (2012) Mol Cell Biol.
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Figure1. 6Model for alternate MSYT acetyltransferase assembly leading to different
substrate specificities.

Lalonde et al. (2013) Genes & development.
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Mutation or down-regulation of ING genes leads to tumor developmental pathways(Piche
and Li, 2010; Ythier et al., 2008). The HBO1 HAT complex contains three PHD fingers
responsible for recognizing various methylated states of H3K4. JADE1 contains two of these
motifs (termed PZP), which cooperate to enable acetylation of nucleosome particles and
recognition of unmethylated H3K4(Avvakumov et al., 2012; Lalonde et al., 2013; Saksouk et al.,
2009). ING4 contains the third PHD finger, which recognizes trimethylated H3K4 (H3K4me3). The
H3K4me3 modification state has been shown to be correlated with the ability of the HBO1 HAT
complex to acetylate H4(Doyon et al., 2006; Foy et al., 2008; Havasi et al., 2013; Lalonde et al.,
2013; Saksouk et al., 2009). Through its recognition of H3K4me3, ING4 has been proposed to
play a lynchpin role in the acetylation process. Thus ING4 can link its aforementioned tumor
suppressor function with chromatin binding, transcriptional activity, and cellular proliferation by
nucleating the complex recruitment process(Avvakumov et al., 2012; Piche and Li, 2010; Ythier et
al., 2008). This is further substantiated by the activity of JADE1 spliced variants. Specifically,
while the longer JADE1L form harbors tumor suppressor activity, the shorter JADE1 variant that
lacks the ING4 binding domain but still binds to HBO1, called JADE1S, does not function as a
tumor suppressor(Avvakumov et al., 2012). Together, JADE1 in the HBO1 HAT complex has
been proposed to function as an intermediary to link HBO1 HAT catalytic activity to ING tumor
suppressor activity through cross talk between two different epigenetic modifications of
methylation and acetylation(Saksouk et al., 2009). The absence of any of the HBO1 HAT
complex subunits leads to diminished acetylation activity on cognate substrates, implying that
these HBO1 HAT complex subunits play important regulatory roles(Avvakumov et al., 2012;
Lalonde et al., 2013; Saksouk et al., 2009).

1.3 Role of auxiliary subunits within histone acetyltransferase complexes

The NuA4 complex, containing catalytic subunit Esa1 as well as additional subunits Epl1,
Yng2, and Eaf6, is the main player in global H4 acetylation in S. cerevisiae, where Esa1 serves
as the only HAT essential for cell cycle (Smith et al., 1998). Recent crystallographic and low-
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resolution EM analyses of the yeast NuA4 complex suggest that Esa1 recognizes its target
residues on the histone tail through a mechanism of substrate specificity that depends on the
other subunits of the complex. The tetrameric core of the NuA4 complex consists of Esa1, Epl1,
Yng2, Eaf6, where the scaffold protein Epl1 serves as the platform for assembly of the complex
(Figure 1.7A). Esa1 and the N-terminus of Epl1 associate to form the catalytic core, while Yng2,
Eaf6 and the C-terminus of Epl1 form a helical bundle. The catalytic core and the helical bundle
regions are connected by a loop in Epl1 referred to as the dual function loop (DFL), as it plays a
key role in both active site rearrangement and in nucleosome binding. The 2.0 Å crystal structure
of Esa1 in the absence of Epl1 suggests that the loop in between α2 -β7 in the active site is
highly conserved among MYSTs and is important for catalysis and for substrate binding (Yan et
al., 2000) (Figure 1.7B). In the absence of Epl1, residues within the Esa1 α2- -7 loop interact
with several α2 residues, but in the recent 3.5 Å crystal structure of the tetrameric NuA4 core
complex, the α2- -7 loop residues R249, L264, and Y265 interact with a highly conserved FRR
(F312, R313, R314) motif in Epl1 to reshape its substrate binding surface(Xu et al., 2016). This
new binding surface has a preference for a substrate with a small residue (G or A) at the P-1
position, allowing Esa1 to specifically target H4 (K5, K8, K12, K16). Additionally, low-resolution
cryo-EM studies and biochemical assays reveal that substrate specificity of the Nua4 complex is
further achieved through the N-terminal portion of the Epl1 DFL, which associates with the
nucleosome and helps position the Nua4 complex on the dish face of the nucleosome with the
active site proximal to the H4 tail. (Figure 1.7A)

A recent 2.4 Å crystal structure of the HBO1 HAT domain in complex with an N-terminal
fragment of BRPF2 reveals that BRPF2 binding modulates HBO1 substrate specificity through a
mechanism differing from the Epl1/Esa1 interaction. The structure reveals that BRPF2 wraps
around the C-terminal part of the HBO1 HAT domain with the interaction stabilized by a network
of hydrogen bonds and Van der Waals interactions between the two proteins (Figure 1.7C).
Unlike Esa1 in the NuA4 complex, the active site of HBO1 does not undergo any conformational
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change when in complex with BRPF2. Further biochemical analysis highlights two different acidic
patches within BRPF2 consisting of residue E41/E43/E45 and E62/D63/D64 that are responsible
for binding and positioning the H3/H4 substrate proximal to the HBO1 active site (Tao et al.,
2017). The crystal structure of HBO1-BRPF2 complex indicates that the histone binding site of
BRPF2 is ~40 Å away from the active site, suggesting that BRPF2 may bind to the core of the
H3/H4 histone, which positions the H3 tail in close proximity to the active site of HBO1(Tao et al.,
2017).
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Figure1. 7X-Ray crystallographic structures of histone acetyltransferase (HAT) complex.
(A)2.0 Å crystal structure of the S. cerevisiae NuA4 complex containing Esa1, Epl1, Yng2 Eaf6.
The active site of Esa1, DFL of Epl1 and the position of the NuA4 complex relative to nucleosome
are indicated. (PDB: 5J9U) (B) Active site comparison of Esa1 in the NuA4 complex versus the
free state. (PDB: 3TO9) (C) 2.4 Å crystal structure of the human HBO1 HAT domain in complex
with an N-terminal fragment of BRPF2 (PDB: 5GK9) overlayed with MOF(PDB: 2GIV) bound to ACoA with substrate binding site indicated.
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1.4 Dissertation objective

Since the discovery of the MYST family, biochemical and structural analysis has led to a
detailed understanding of the catalytic domain of these proteins. However, how the subunits of
the respective MYST HAT complex contribute to the activity and substrate selectivity of the
complex was not known. For my dissertation, I dissected the molecular role of the subunits of the
HBO1 complex for HBO1 acetyltransferase activity and substrate specificity. Together, my
studies have important implications for understanding the molecular basis for HBO1 regulation
within the catalytic complex and point to the particular importance of the scaffold protein JADE for
function of the HBO1 complex. My studies also have broader implications for the development of
HBO1-selective MYT inhibitors.
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Chapter 2- Scaffold protein JADE is important for assembly and activity of the HBO1 HAT
complex
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2.1 Abstract

HBO1 HAT complex has been shown to be responsible for global H4 acetylation.
Previous studies have demonstrated that JADE serves as a scaffold protein to assemble HBO1
HAT complex. Through a DNA splice event, JADE can assemble 2 different biologically relevant
forms of HBO1 HAT complexes. Subunits within the HBO1 HAT complex possess chromatin
recognition domain that allow the complex to be properly localized throughout chromatin.
Although we have some information about how the complex may be recruited to chromatin, the
relative contributions of subunits of the HBO1 HAT complex to the catalytic activity of HBO1 has
not been previously dissected. In this chapter, we demonstrate that JADE is the main subunit in
the HBO1 HAT complex that contributes to assembly and the overall activity of the HAT complex
towards H4 substrate.
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2.2 Introduction

The human MYST family of HATs, comprised of MOZ, Tip60, HBO1, MORF, and MOF,
are evolutionarily conserved with S. cerevisiae Esa1 and characterized by a highly conserved
MYST fold within the catalytic domain (Marmorstein and Zhou, 2014). The structure of the Gnc5
and PCAF catalytic HAT domain bound to an H3K14-containing peptide reveals extensive
backbone interaction with surrounding residues on the H3 tail, thus demonstrating that the
catalytic Gcn5/PCAF HAT domain can bind its lysine substrate independently (Rojas et al., 1999).
In contrast to the Gcn5/PCAF HATs, MYST family HATs are thought to have lower affinity
towards their substrates and are generally more promiscuous toward multiple lysine residues
within the same histone tails, thus requiring other subunits of their respective complexes to
provide substrate specificity (Marmorstein and Zhou, 2014; Rojas et al., 1999).

HBO1, in particular, functions in the context of a multi-protein HAT complex containing
JADE1/2/3, HBO1, ING4/5 and Eaf6 to regulate DNA replication, transcription, and other
important cellular processes(Avvakumov et al., 2012) (Figure 2.1). The activity of HBO1 is
heavily dependent on the regulatory proteins within the HBO1 HAT complex, which otherwise
have their own functions in cellular proliferation and tumor suppression pathways. For example,
JADE1 was initially identified as a protein partner of von Hippel-Lindau tumor suppressor to
regulate cellular oxygen sensing(Zhou et al., 2002). A recent study demonstrated an HBO1
complex containing the BRPF1 protein in place of JADE1 has specificity for H3 acetylation, rather
than the H4 acetylation preferred by the JADE1 containing complex. This suggests JADE1 plays
an important role for specifying H4 acetylation by the HBO1 complex(Lalonde et al., 2013).
Another member of the complex, ING, is an inhibitor of growth protein responsible for growth
regulation in eukaryotic organisms. Mutation or down-regulation of ING genes leads to tumor
developmental pathways(Piche and Li, 2010; Ythier et al., 2008). The absence of any of the HAT
complex subunits leads to diminished acetylation activity on the cognate substrates, implying that
these HBO1 HAT complex subunits play important regulatory roles(Avvakumov et al., 2012;

19

Lalonde et al., 2013; Saksouk et al., 2009). Lastly, Eaf6, is a MYST associated protein with an
unknown function.
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Figure 2. 1The schematic representation of 2 different HBO1 HAT complex formation due
to splice variants on JADE

(A) JADE1-L forms a tetrameric HBO1 HAT complex with HBO1,Eaf6,ING4/5. (B) JADE1-S
forms a dimeric HBO1 HAT complex with HBO1.
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2.3 Results

2.3.1 JADE functions as a scaffold protein to bring other subunits together to form different HBO1
HAT complexes

Previous studies of the HBO1 HAT complex suggest that other subunits of the complex
are important for HBO1’s activity. However, the actual mechanism of how these subunits
modulate the activity of the catalytic enzyme in the HAT complex is still unknown. As mentioned
earlier, the HBO1 HAT complex exists as two different forms with different functions in the cell.
The formation of these two different HBO1 HAT complexes is due to a DNA splicing event that
occurs on JADE leading to either JADE short (JADE-S) or JADE long (JADE-L) variants. The
main difference in between the two variants is that JADE-S forms a hetrodimeric complex with
HBO1 whereas JADE-L forms a hetroterameric complex with HBO1/ING/Eaf (Figure 2.1). To
study the catalytic contribution of each subunit in the HBO1 HAT complex, we initially set out to
study if two different forms of the HBO1 HAT complex could be assembled and purified from
recombinant proteins. Baculovirus infected Sf9 cells were used to express full-length HBO1
assembled as either 4 protein HBO1 HAT complex (HBO1/JADE3/ING4/Eaf6), or 2 protein HBO1
HAT complex (HBO1/JADE3). The cells were co-infected with expression plasmids expressing
each protein for the 2 and 4 protein complexes. HBO1 complexes were purified to homogeneity
using affinity and gel filtration chromatography. Specifically, the soluble fraction of the cell lysate
was incubated with antibody based FLAG resin followed by 3XFLAG peptide elution. For the cells
that were co-infected with 4 protein expression vectors, Flag-HBO1 co-purified with HA-JADE3,
HA-ING4, HA-Eaf6 in solution and the complex remained stably associated. The co-purification of
the full HBO1 HAT complex was further verified by running the protein on a Superose-6 size
exclusion column (Figure 2.2 in blue). The protein complex co-migrated on the Superose-6
column eluting at a molecular marker that was consistent with a 1:1:1:1 globular protein complex,
informing us that the proteins were likely folded correctly. In a similar fashion, the 2-protein
complex containing Flag-HBO1 and HA-JADE3 was prepared and also co-migrated on the
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Superose-6 column consistent with a 1:1 globular protein complex verifying their proper fold
(Figure 2.2 in red). After the 4-protein and 2-protein HBO1 HAT complex was purified, the
presence of JADE3, ING4, Eaf6 or JADE3 was confirmed by anti-HA western blot, respectively
(data not shown).
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Figure 2. 2JADE functions as a scaffold protein to assemble different HBO1 HAT complex

(A)Red – 2 protein complex (Flag-HBO1/HA-JADE3) ~140KDa, Blue – 4 protein (Flag-HBO1/HAJADE3/HA-ING4/ HA-Eaf6) ~200KDa, Black – Standard (670KDa, 158KDa, 44KDa, 17KDa,
1.35KDa) B. SDS-PAGE gel of the 2 protein complex and 4 protein complex post Suprose 6 gel
filtration chromatography and HBO1 after Flag affinity purification.
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2.3.2 Comparison of the Kinetic parameters of the 2-protein and 4-protein HBO1 complexes
indicates that JADE is sufficient for maximal HBO1 activity

As described earlier, the HBO1 HAT complex exists as 2 biologically relevant forms
either containing HBO1/JADE/ING/Eaf or HBO1/JADE. These 4-protein or 2-protein HBO1 HAT
complexes have different functions in cells(Avvakumov et al., 2012) (Figure 2.1). To elucidate the
kinetic contribution of the ING4 and Eaf6 subunits of the 4-protein HBO1 complex, we compared
the steady state parameters, Vmax and Km, of the 2- and 4-protein HBO1 complexes using
substrate saturation curves with A-CoA (~500uM) and H4 peptide (~2mM). We employed a
radioactive acetylation filter-binding assay described in the materials and method section. Using
this method, we used the Michaelis-Menten kinetic model to obtain the steady state parameters.
Although the curves did not fit perfectly with the Michaelis-Menten model, we were able to
calculate the Km and Vmax values of the 2 and 4 protein HAT complexes (Figure 2.3). Using the
Michaelis-Menten curve, we demonstrated that the Km and Vmax of these two HAT complexes
were comparable to each other. Specifically, calculated Km values of A-CoA were 3.1uM and
1.8uM for 4-protein and 2-protein complexes respectively. In addition, calculated Km values of the
H4 peptide was 229.1uM and 249.1uM for 4-protein and 2-protein complexes respectively.
Furthermore, the Vmax values of A-CoA and H4 peptide were very similar for both complexes. In
addition, HBO1 alone showed a much lower activity, which did not saturate under the tested
conditions.
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Figure 2. 3 JADE is the main player of the HBO1 HAT complex in catalytic contribution.

Saturation curve of A-CoA and H4 of the 2 protein complex (Flag-HBO1/HA-JADE3) and 4
protein complex (Flag-HBO1/HA-JADE3/HA-ING4/ HA-Eaf6) and HBO1 using the MichaelisMenten kinetic model. The output of the assay is displayed as counts per minute (CPM) (A) ACoA (B) H4 peptide(1-19)
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Although the HBO1 alone sample did not show much acetyltransferase activity towards
H4 substrate, the kinetic parameters of the 4-protein and 2-protein HBO1 HAT complexes were
relatively comparable to each other. The fact that the 2-protein complex was as active as the 4protein complex indicates that ING4 and Eaf6 are possibly involved in non-catalytic functions of
the HBO1 HAT complex, such as stability, or localization of the HAT complex to the correct region
of the chromatin. Together, our data suggests that JADE is sufficient for HBO1 to reach its
apparent maximum catalytic potential towards the substrate.

2.3.3 The N-terminal Domain I of JADE forms a stable complex with the HBO1 HAT domain.

After we determined that JADE is the main contributor of the HBO1 complex in enhancing
HBO1 activity towards its substrate, we sought to further understand the interaction between
these two proteins using the minimal interacting regions. The three different JADE paralogs that
can interchangeably assemble within the HBO1 HAT complex are highly conserved (Avvakumov
et al., 2012) (Figure 2.4). For ours studies, we employed JADE1. Previously, Cote and coworkers
identified Domain I of JADE1/2/3 to be responsible for interacting with the HAT domain of
HBO1(Avvakumov et al., 2012). Based on this, we sub-cloned an N-terminal DNA construct
encoding JADE1 (1-188) containing Domain I into a bacterial expression vector. Using the
sequence conservation of HBO1 orthologs from different species, we selected residues 302-611
as the HBO1 HAT domain, and sub-cloned a DNA fragment encoding this region to produce a
recombinant HBO1 HAT domain in bacteria (Figure2.5). These recombinant proteins were
purified through a series of affinity, ion exchange, and size exclusion chromatography steps.
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Figure 2. 4 Primary sequence alignment of JADE1/2/3/ Paralogs.

The red region indicates evolutionary conservation
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Figure 2. 5 Primary sequence alignment of HBO1 and its orthologs from various species
all the way from yeast to human.

The sequence conservation and the crystal structure of yeast ESA HAT domain was used to
design HBO1 HAT domain construct. The red region indicates evolutionary conservation

30

To determine if the minimal interacting domains of each protein were sufficient to interact
in solution, each of these separately purified proteins were mixed together with one protein in
excess and ran on a Superdex 200 size exclusion column. As expected, the HBO1 and JADE1
complex co-migrated with excess HBO1 or JADE1 eluting at a higher retention volume (Figure
2.6). In this study, we have demonstrated that the minimal interacting domains of HBO1 and
JADE1 were able to form a stable hetero dimeric complex consistent with a 1:1 globular protein
complex according to the retention volume on the s200 column. In addition, the fact that the
protein complex eluted at the right molecular mark outside of the void volume indicates that the
protein complex we prepared was properly folded.
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Figure 2. 6JADE domain I forms a complex with HBO1 HAT domain.

(A) S200 size exclusion chromatography run with HBO1 JADE1 complex with either HBO1 or
JADE1 in excess (B) The protein sample of each fraction was resolved on SDS-PAGE gel
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The purified HBO1 HAT domain (302-611) undergoes an N-terminal degradation over
time (Figure 2.7A). The resulting degradation product was analyzed by mass spectroscopy,
which indicated that HBO1 gets hydrolyzed around residue 329 (Figure 2.8A). Using Psi Pred
secondary structure prediction(Jones, 1999), we were able to determine that the hydrolysis
occurs at a predicted flexible region of the HAT domain (Figure 2.8B). We attempted to express
and purify the hydrolyzed product. However, HBO1(329-611) was not soluble indicating that
residues 302-329 of HBO1 play an important role in overall folding and stability of the HAT
domain. Interestingly, when the HBO1 HAT domain (302-611) is purified with JADE1(1-188) as a
complex, the N-terminal loop is protected and is able to remain as an intact protein, which results
in a stable heterodimeric complex. This result reveals that when HBO1 and JADE1 are purified
together as a stable complex, JADE1(1-188) protects the N-terminal region of the HBO1 HAT
domain from degradation. In addition, HBO1 (302-611) and the HBO1(302-611)/JADE1(1-188)
complex were used for a Thermal Shift Assay (using Sypro Orange binding as a readout for
protein unfolding) to test their overall stability by measuring their apparent melting temperature.
This study revealed that JADE1 (1-188) binding to the HBO1 HAT domain stabilized the HAT
domain by ~5C°(Figure 2.7B). As a positive control, we demonstrated that the addition of acetylCoA increased the apparent melting temperature of the HBO1 HAT domain by ~3C° suggesting
that we have a well-folded HAT domain that is able to bind cofactor (data not shown).
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Figure 2. 7JADE1 projects the N-terminal end of HBO1 HAT domain.

(A) HBO1(302-611) and HBO1(302-611)/JADE1(1-188) complex resolved on SDS-PAGE gel (B)
Thermal shift assay of HBO1(302-611) in blue and HBO1(302-611)/JADE1(1-188) complex in red
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Figure 2. 8HBO1 is hydrolyzed at the flexible region in the HAT domain

(A) LC-MS/MS analysis of the degraded fragment of HBO1 (B) Psi Pred secondary structure
prediction around the site of degradation
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2.3.4 Domain I of JADE is sufficient for activation of HBO1 acetyltransferase activity towards H4
peptide

Having demonstrated that JADE1 (1-188) and the HBO1-HAT domain form a stable
complex, we next set out to determine the catalytic contribution of JADE1(1-188) to HBO1
acetylation activity towards an H4 peptide. To do this, we titrated JADE1(1-188) up to 10-fold
molar excess to HBO1(302-611) and tested for acetyltransferase activity using a radioactivebased acetyltransferase assay. These studies demonstrate that the recombinant HBO1 HAT
domain harbors acetyltransferase activity towards H4 peptide, and that this activity increases in a
dose response manner upon titration of JADE1 domain I (Figure 2.9). The size-exclusion
chromatography run of HBO1 and JADE1 suggested that the complex has a stoichiometry of 1 to
1. To confirm this stochiometry, we created the fusion construct JADE1(1-188)-HBO1(302-611) to
force a 1:1 stoichiometry and test if additional JADE1(1-188) further stimulates catalytic activity of
the fusion protein. The fusion construct was created by cloning both fragments into the same
vector, expressing as a single polypeptide that is purified in a similar manner as HBO1(302-611).
In agreement with the 1:1 JADE1(1-188)/HBO1(302-611) stoichiometry, we observed that while
the fusion construct showed much increased activity compared to HBO1 (302-611) alone, it was
not stimulated by titration of excess JADE1(1-188) (Figure 2.9). Although crystallographic
information on the complex may be necessary to fully capture the multimerization state of the
complex, this data is consistent with a 1:1 JADE1(1-188)/HBO1(302-611) stoichiometry.
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Figure 2. 9HBO1 HAT domain responses to addition of JADE Domain I in acetyltransferase
activity

Acetyltransferase activity of HBO1(red) and JADE1-HBO1 fusion(blue) done with H4 peptide as
the substrate. JADE is titrated up to 10 fold molar excess.
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In addition, to further analyze the catalytic contribution of JADE1(1-188) to HBO1 HAT
domain acetyltransferase activity, we have determined the steady state parameters, Vmax and Km
using substrate saturation curves with A-CoA (~100uM) and H4 peptide (~1mM) (Figure 2.10).
Here, we demonstrated that the minimal catalytic core HBO1(302-611)/JADE1(1-188) of the
HBO/JADE HAT complex is sufficient for interaction as well as catalysis. Specifically, when HBO1
HAT domain was tested for its acetyltransferase activity with the H4 peptide as the substrate,
JADE1(1-188) affected both Km and Vmax on A-CoA by two- and three-fold increase, respectively.
However, JADE1(1-188) only increased the Vmax on H4 peptide by three-fold while not affecting
the Km. The fact that JADE1 did not affect the Km while increasing the Vmax on H4 peptide
suggests that JADE1 is able to increases the enzymatic rate of HBO1 without contributing to the
overall affinity of the HBO1 HAT domain and H4 tail. Although a further study is necessary to fully
understand how JADE1 activates HBO1 for acetyltransferase activity, our data suggests that
JADE1 affects the enzymatic rate of HBO1 by modulating the active site either through stability or
allostery.
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Figure 2. 10JADE1 Domain I (1-188) is able to stimulate activity of the isolated HBO1 HAT
domain towards H4 peptides

Saturation curve of A-CoA and H4 of the HBO1(302-611) and HBO1(302-611)/JADE1(1-188)
using the Michaelis-Menten kinetic model. The output of the assay is displayed as counts per
minute (CPM) (A) A-CoA (B) H4 peptide (1-19)
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2.4 Discussion

HBO1 functions in a multiprotein HAT complex and has been shown to be the main
player in H4 acetylation(Lalonde et al., 2013). Previous studies have demonstrated that other
subunits of the complex contribute to H4 acetyltransferase activity of HBO1(Avvakumov et al.,
2012). There are many components that may contribute to the overall activity of HBO1, such as
chromatin recognition domain within the complex that allows the complex to be localized to the
correct region of chromatin. However, the relative contributions of subunits of the HBO1 complex
to HBO1 catalytic activity has not been previously dissected. In this study, we demonstrate that
the JADE subunit, Domain I in particular, of the HBO1 complex plays the most significant role in
HBO1 H4 acetyltransferase activity. We also find that JADE protects the N-terminal region of the
HAT domain, which seems to be important for overall stability of the HAT domain. This data is
consistent with previous studies demonstrating that HBO1 can complex either with JADE or
BRPF leading to either H4 or H3 tail acetylation, respectively(Lalonde et al., 2013).

A recent crystal structure of the HAT domain of HBO1 in complex with an interacting peptide of
BRPF2 reveals that BRPF2 wraps around the N-terminal end of the HAT domain(Tao et al.,
2017). This observation is in agreement with our hypothesis that JADE1 might be interacting and
protecting the N-terminal end of the HAT domain. The authors of the HBO1-HAT/BRPF2 complex
also demonstrate that BRPF2 binding to the N-terminal region of the HBO1-HAT domain confers
H3 acetylation activity, and in analogy we propose that JADE binding to N-terminal region of the
HBO1-HAT domain confers H4 acetylation activity.

2.5 Materials and Methods:

2.5.1 Full-length HBO1 HAT complexes

Flag-HBO1, HA-JADE1/3, HA-Eaf6, and HA-ING4 in pVL vectors were provided by Jacques Côté.
Baculovirus Sf9 insect cells were used to prepare 4-protein and 2-protein HBO1 complexes and
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FLAG-HBO1. pVL-FLAG-HBO1, pVL-HA-JADE3, pVL-HA-Eaf6, and pVL-HA-ING4 vectors were
co-infected for the 4-protein complex, and pVL-FLAG-HBO1, pVL-HA-JADE3 were co-infected for
the 2-protein complex. Cells were harvested at 48 hours by centrifugation at 3500 RPM. Cells
were lysed by sonicating in lysis buffer (20mM Tris(pH 8) 500mM NaCl, 1mM BME, 0.1mg/ml
PMSF/ c0mplete, EDTA-free protease inhibitor cocktail tablets). The post-lysis sample was spun
down at 20,000 RPM for 30 minutes and the soluble fraction of the post-lysis sample was applied
to Anti-FLAG Resin (Sigma Aldrich) and incubated for an hour at 4°C. Proteins were eluted with
500ug/ml 3XFLAG peptide (Sigma Aldrich) in the lysis buffer.

2.5.2 Suprose-6 size exclusion chromatography.

3XFLAG peptide eluted proteins were concentrated with 50KDa cutoff concentrators (Millipore)
and injected onto aSuprose-6 size-exlusion column (GE) with a column flow rate of 0.2ml/min.
Elutions were fractionated and collected in 1 ml fractions.

2.5.3 JADE1/2/3 N-terminal sequence alignment

Sequence alignment for JADE1/2/3 was carried out using ClustalW2(Sievers et al., 2011) and
was further formatted using ESPript (3.0) for more optimal sequence homology of JADE
homologs(Gouet et al., 2003).

2.5.4 Recombinant HBO1 and JADE1 protein production in bacteria

DNA encoding HBO1 and JADE1 protein constructs were generated by PCR amplification of the
corresponding DNAs, which were cloned into pRSF or pDB.His.MBP vectors using Sacl/NotI sites
with a cleavable N-terminal affinity tags (GST-,6XHIS-,MBP-). Cells containing these cloned
constructs were grown and expressed using BL21(DE3) cells in LB. Cells were induced for
protein over-expression at an OD ~0.6 with 0.5mM IPTG for 16-18 hours at 18 °C. Cells were
harvested by centrifugation at 4000 RPM and lysed by sonicating in lysis buffer (20mM Tris(pH 8)
500mM NaCl, 5mM BME, 0.1mg/ml PMSF). The lysed samples were spun down at 20,000 RPM
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for 30 min. and the soluble fraction of the lysed samples were applied to either, Pierce
Glutathione Agarose resin(Thermo), Amylose resin (NE Biolabs) or Ni-NTA resin (Thermo) for
batch binding at 4°C for 1 hour. Samples were washed with 20 column volumes (CV) of wash
buffer (20mM Tris( pH 8), 500mM NaCl, 5mM BME) then eluted with eluant with either 30mM
reduced L-glutathione(GST), 20mM maltose monohydrate(MBP), or 300mM Imidazole(6XHIS).
Proteins were further purified to homogeneity by either HiTrapQ(GE Healthcare) anion exchange
for JADE1 constructs or HiTrapHP(GE Healthcare) cation exchange for HBO1 and fusion
constructs. Ion exchange chromatography was performed using a NaCl gradient from 100mM to
1M over 30 CV. To ensure the proper fold of recombinant proteins, they were subjected to size
exclusion chromatography (SEC) using a Superdex 200 column in 20mM Tris(pH 8), 500mM
NaCl, 5 mM BME.

2.5.5 Histone acetyltransferase(HAT) activity assay

HBO1 HAT activity was measured using a previously described HAT assay with

14C

labeled Ac-

CoA (50-60 mCi/mmol; Moravek)(Yan et al., 2002). A time course for the reaction was initially
performed to determine the linear range of enzyme activity at an enzyme concentration of
200nM(HBO1)/1uM(HBO1-HAT complex) and saturating concentrations of AcCoA (300uM) and
H4 peptide (1mM). The HAT reaction was performed using a buffer containing 20mM Tris (pH
7.5), 500mM NaCl, 0.25mg/ml BSA for 1 hour at 20°C in a volume of 50uL. 20uL of the reaction
was spotted on P81 filter paper. The positively charged and C14-labeled H4 peptide was captured
on the filter paper, while free

14C-labeled

Ac-CoA was washed away. The paper was analyzed

using Liquid Scintillation(Berndsen and Denu, 2005). The amount of

14C-labeled

H4 peptide

bound to the paper is directly proportional to the amount of acetyl group transferred from the
cofactor to peptide, thus the data was used to evaluate HBO1 acetyltransferase activity(Berndsen
and Denu, 2005). All reactions were done in duplicate. The output of the enzyme was plotted as
Counts Per Minute(CPM).
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Chapter 3 -The scaffolding protein JADE1 physically links the acetyltransferase subunit
HBO1 with its histone H3/H4 substrate

This research was performed in a collaboration with Dr. Catherine Lachance, and Dr. Jacques
Côté of the Laval University Cancer Research Center. Dr.Catherine Lachance, and Dr. Jacques
Côté carried out the cellular experiments in section 3.3.7. Repeated with permission from Han, J.
et al. The scaffolding protein JADE1 physically links the acetyltransferase subunit HBO1 with its
histone H3-H4 substrate. J Biol Chem293, 4498-4509, doi:10.1074/jbc.RA117.000677 (2018).
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3.1 Abstract

The human HBO1 enzyme regulates DNA replication, cell proliferation and development
in the context of a multi-protein histone acetyltransferase (HAT) complexes containing ING4/5,
MEAF6 and scaffolding proteins JADE1/2/3 or BRPF2/3 to acetylate histone H4 H4K5/8/12 or
H3K14, respectively. Within the four-protein complex, the JADE protein has been demonstrated
to be the determinant for histone H4 substrate specificity of the HBO1 HAT complex. We carried
out in vitro studies with recombinant proteins to dissect the specific regions and activities of
HBO1 and JADE1 that mediate histone H4 acetylation by the HBO1 HAT domain. We find that
JADE1 increases the catalytic efficiency of HBO1 acetylation of a H3/H4 substrate by about 5-fold
through a N-terminal 21-residue HBO1 and Histone Binding Domain (HHBD) and a nearby
second Histone Core Binding Domain (HCBD). We also demonstrate that HBO1 contains an Nterminal Histone Binding Domain (HBD) that makes additional contacts to H3/H4 independent of
JADE1, interactions with histones and the HBO1-HBD does not significantly contribute to the
overall HAT activity of HBO1. Cellular experiments employing JADE1 deletions recapitulate these
in vitro interactions and their roles in HBO1 histone acetylation activity. Together, these studies
demonstrate that the N-terminal region of JADE1 functions as a platform to bring the catalytic
HBO1 subunit together with it its cognate H3/H4 substrate for histone acetyltransferase activity.

3.2 Introduction

Histone acetylation, a covalent modification on lysine residues of histones, predominantly
in the N-terminal tail regions, regulates local and global chromatin dynamics—thus playing an
important role in modulating DNA accessibility and gene expression in all eukaryotic organisms.
Generally, hyperacetylation and hypoacetylation are observed in transcriptionally active and
inactive regions of the chromatin, respectively(Havasi et al., 2013; Kornberg and Lorch, 1999;
Sapountzi and Cote, 2011; Strahl and Allis, 2000; Thomas and Voss, 2007). Histone acetylation
has been shown to promote transcription in at least two ways. First, acetylation neutralizes the
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lysine positive charge, thus altering its physiochemical properties and making the local chromatin
environment more accessible for gene transcription activation(Sapountzi and Cote, 2011).
Second, lysine acetylation generates a docking recognition sites for various gene-activating
proteins containing acetyl-lysine recognition domains such as bromodomains(Havasi et al., 2013;
Jenuwein and Allis, 2001; Peterson and Laniel, 2004; Taverna et al., 2007; Turner, 2000).
Therefore, the tight regulation of acetylation on lysine residues within histones, as well as the
enzymes that mediate these modifications, are critical to maintain normal gene expression and
regulation.

The enzymes that mediate histone acetylation are histone acetyltransferases (HATs),
while the enzymes that convert acetyl-lysine residues within histone back to lysine are histone
deactylases (HDACs)(Allis et al., 2007). HDACs are grouped into four classes according to their
functional properties and sequence conservation, which fall into two conserved structural folds
(classes I, II, IV and the class III sirtuins). HATs show considerably more sequence and structural
diversity than HDACs, forming at least five different families, Gcn5/PCAF, MYST, p300/CBP,
Rtt109 and HAT1. HATs typically function within multiprotein complexes in vivo where their
substrate specificities and activities are modulated by the other subunits of the respective HAT
complexes(Lalonde et al., 2013; Lalonde et al., 2014). Human HBO1 (also referenced as KAT7 or
MYST2), a member of the MYST family, regulates DNA replication(Doyon et al., 2006; Miotto and
Struhl, 2008), cell proliferation and development(Avvakumov et al., 2012). Consistent with its role
in gene expression, the HBO1 HAT complexes are localized at the transcription start sites and
coding regions of active genes in the genome(Saksouk et al., 2009), and is responsible for the
majority of H4(Doyon et al., 2006; Foy et al., 2008; Miotto and Struhl, 2010) and H3K14(Feng et
al., 2016; Kueh et al., 2011) acetylation. HBO1 has also been shown to play more specific roles
in activating the expression of key genes in development and embryonic patterning(Kueh et al.,
2011). The aberrant activity of HBO1 has been correlated with several cancers. HBO1 has been
shown to be over-expressed in MCF7 and Saos-2 established cancer cell lines and in a subset of
human primary cancers such as carcinomas of testis, breast, and ovary(Duong et al., 2013;
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Iizuka et al., 2009). Finally, a HBO1 catalytic defective mutant inhibits MCM complex loading onto
the origin, indicating that HBO1 functions as a DNA replication co-activator in addition to its
transcriptional roles(Havasi et al., 2013; Miotto and Struhl, 2008, 2010).

JADE1 has been demonstrated to act as a platform to assemble the tetrameric HBO1
HAT complex for histone H4 acetylation, with a region of JADE1 N-terminal to the JADE1 PHD
fingers (called region I) shown to recruit HBO1, and a region of JADE1 C-terminal to the JADE1
PHD fingers (called region II) shown to recruit the ING/MEAF6 subcomplex(Avvakumov et al.,
2012). It has also been shown that a modified tetrameric complex, in which BRPF replaces JADE
has specificity for H3K14 acetylation(Lalonde et al., 2013). These studies highlight the importance
of BRPF and JADE subunits in dictating histone substrate specificity. While a recent study has
revealed the molecular basis for how BRPF mediates H3K14-specific acetylation by HBO1(Tao et
al., 2017), the molecular basis for how JADE potentiates the H4 specific activity of HBO1 is not
known. Given this gap in knowledge, we set out to dissect the specific regions and activities of
JADE1 that mediate histone H4 acetylation by the HBO1 HAT complex. We find that JADE1
contains specific HBO1 and histone binding regions that serves to increase the catalytic efficiency
of HBO1 acetylation of histone H4. Implications of these studies for the differential regulation of
HBO1 by JADE1 and BRPF1 paralogs are discussed.

3.3 Results

H4 tails are a part of H3/H4 histone heterodimers and heterotetramers in the cell and are never
found alone in the cell. For this reason, our subsequent studies of HBO1 complex activity
employed H3/H4 complexes as substrates. To better understand the substrate selection, we
prepared 4 different constructs of the full length and tailless (TL) histones; H3/H4, H3(TL)/H4,
H3/H4(TL), H3(TL)/H(TL) (Figure 3.1). Each of these histone pieces was prepared as indicted in
the experimental procedure section in chapter 3. From this experiment we were able to see that
the main target of the HBO1 on the H3/H4 was the lysine residues on the tail. More importantly
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JADE mainly stimulated HBO1's activity toward H4 tails of the histone. In this chapter, we will
dissect the roles of two newly identified N-terminal JADE domains that influence substrate
recruitment for substrate specificity of the HBO1 HAT complex.

Figure 3. 1HBO1 acetyltransferase activity on different histone substrates

Acetytransferase activity of HBO1 with 4 different histone constructs and its response to addition
of 2 different JADE1 constructs. The output of the assay is displayed as counts per minute (CPM)
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3.3.1 A 21-residue segment of JADE1 directly contacts the HBO1 HAT domain and histone
substrate to facilitate acetylation of free histones

It was previously demonstrated that an N-terminal region of JADE1 between residues 90199 participated in HBO1 catalytic activity(Avvakumov et al., 2012). This region of JADE1
contains sequence conservation within residues 115-179 of yeast to human proteins associated
with ING/MYST-containing HAT complexes(Avvakumov et al., 2012; Lalonde et al., 2013). We
also noted an additional region of sequence conservation among the JADE proteins just Nterminal to this region (Figure 3.2A). To map the region of the JADE1 N-terminus that directly
interacts with the HBO1-HAT domain, we used pull down experiments with the HBO1-HAT and
N-terminal truncation constructs of JADE1 (Figure 3.2B). These experiments revealed that MBPJADE1(1-188) and MBP-JADE1(60-188) were able to pull down the HBO1-HAT, while MBPJADE1(80-188) was not. These data revealed the importance of residues 60-80 of JADE1 for the
direct interaction with the HBO1-HAT. To further narrow down the key residue(s) within this 21residue segment critical for the interaction with the HBO1-HAT domain, we introduced triple
alanine mutations spanning residues 60 to 80 within the context of MBP-JADE1(1-188). These
studies revealed that each of the mutants resulted in no detectable HBO1-HAT pull down (Figure
3.2C). The observation that each of the JADE1 mutants disrupted HBO1-HAT interaction
suggested that either the entire JADE1(60-80) domain makes important contacts to the HBO1HAT or that the domain contains a binding surface and tertiary structure that are both important
for HBO1-HAT interaction. To more quantitatively assess the binding of the JADE N-terminal
region to the HBO1-HAT, we performed Isothermal Titration Calorimetry (ITC) using various
constructs of JADE1. The ITC results were consistent with the pull-down data, demonstrating that
JADE1(60-188) showed significant binding to the HBO1-HAT with a Kd of ~2.4uM and a
stoichiometry of ~1:1, while JADE1 (80-188) showed no detectable binding (Figure 3.2D).
Strikingly, a peptide of residues 55-85 of JADE1 showed binding with a comparable dissociation
constant (Kd= 4.18uM) to JADE1(60-188) demonstrating that residues 60-80 of JADE1 are
essential for HBO1-HAT binding.
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We next asked if residues of 60-80 of JADE1 are also able to interact with histones to
potentially bridge the HBO1-HAT acetylation of histones. To do this, we carried out pull-down
studies of MBP-JADE1 N- and C-terminal deletion constructs with HBO1-HAT plus H3/H4 (Figure
3.2B). These studies revealed that only JADE1 constructs harboring residues 60-80 of JADE1
were able to interact with both the HBO1-HAT and H3/H4, confirming that JADE1 residues 60-80
bridge HBO1-HAT/histone interactions. Notably, JADE1 constructs starting at residue 60 and
extending to residue 188, showed more robust pull down with HBO1-HAT and histones than
JADE1 constructs harboring only residues 60-80, suggesting that additional regions of JADE1
between residues 108 and 188 also contribute to HBO1/histone interactions (Figure 3.2B).
Based on the HBO1-HAT and histone binding properties of residues 60-80 of JADE1, we refer to
it as the HBO1 and Histone Binding Domain (JADE1-HHBD).
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Figure 3. 2An N-terminal region of JADE1 binds HBO1.

(A) sequence alignment of the N-terminal region of JADE1/2/3 paralogs, with the highest degree
of conservation shaded in red and conservative substitutions colored in red. The HBO1 and
HHBD are highlighted. (B) MBP-JADE1 pulldowns with various N-terminal and C-terminal
deletion constructs of the HBO1-HAT domain and H3/H4 complex with results resolved on SDSPAGE. MW Std., molecular weight standard. (C) MBP-JADE1 pulldowns of the HBO-HAT with
JADE1 triple alanine mutations with results resolved on SDS-PAGE. (D) ITC studies of JADE1
constructs titrated into the HBO1-HAT, showing the heat profile (top) and the calculated binding
isotherm (bottom). Thermodynamic data calculated from this data are shown at the right.

We then asked if the minimal region of JADE1 that facilitates HBO1 and histone binding
is sufficient to potentiate HBO1-HAT activity toward histone tail acetylation. To do this, we titrated
JADE1 (55-85) and JADE1(1-188) into the HBO1-HAT and H3-H4 complex and assayed for
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histone acetyltransferase activity (Figure 3.3). This analysis revealed that titration of JADE1(5585) in vast excess resulted in only marginal effects on HBO1 histone acetyltransferase activity,
while titration of JADE1(1-188) showed significantly more potentiation of HBO1 histone
acetyltransferase activity, to a level of about 6-fold relative to no added titrant. Taken together
with the previous data showing that residues 60-80 of JADE1 bridges HBO1-HAT-histone
interaction, these data demonstrated that residues 60-80 of JADE1 contribute to but are not
sufficient to mediate HBO1 acetylation of histones.
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Figure 3. 3JADE1 requires an additional N-terminal region for H3/H4 binding and HBO1
HAT potentiation.

Shown is the titration of JADE1 constructs (55–85 and 1–188) from 0- to 16-fold molar excess of
HBO1 HAT domain tested for acetyltransferase activity on the H3/H4 complex. Radioactive
counts are converted to enzyme rate as described under “Experimental procedures.”

3.3.2 JADE1 contains a second histone binding domain that contributes to HBO1 acetylation of
histone H4 substrate by anchoring the HBO1/JADE1 complex to the histone core.

Inspection of the pull-down experiments of Figure 3.2B reveals that an additional region
of JADE1, within residues 108-188, interacts with histones but not the HBO1-HAT and the histone
acetyltransferase activity assay of Figure 3.3 further suggests that regions within JADE1 residues
80-188 are also required to fully potentiate HBO1-HAT histone acetyltransferase activity. Based
on these studies, we carried out further studies to define the regions of JADE1 and histones that
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mediate this interaction. To specifically probe the requirement for the histone tails for JADE1
interaction, we carried out MBP-JADE1(60-188) pull down with H3/H4 with either full-length or
tailless H3 and/or H4 subunits. These studies revealed that JADE1(60-188) pulled down all of the
histone complexes, including the completely tailless complexes (H3(TL)-H4(TL)) (Figure 3.4A).
These pull-down experiments demonstrated that the primary JADE1(60-188) binding site exists
on the core of the H3/H4 complex.

Previous studies indicate that JADE1 facilitates HBO1 H4-specific tail acetylation(Lalonde
et al., 2013). For this reason, we asked if JADE1 makes an additional direct or HBO1 dependent
contact with the H4 tail. To test this, we prepared GST tagged H4 tail 1 to 19 and performed a
GST pull down with JADE1 (1-188) in the presence of the HBO1-HAT. This experiment revealed
that HBO1-HAT is unable to interact directly with the isolated H4 histone tail in the absence or
presence of JADE1(1-188) (Figure 3.4B), consistent with the conclusion that JADE1 histone core
binding is required for HBO1-HAT acetylation of the histone H4 tail. We refer to the domain of
JADE1 that mediates H3/H4 core binding as the Histone Core Binding Domain (JADE1-HCBD).

MBP pull downs with JADE1 deletion constructs and H3/H4 (Figure 3.2B) suggests that
JADE1 contains 2 histone binding sites, JADE1(60-80), JADE1(104-188). To more quantitatively
evaluate the histone binding properties of these two regions of JADE1, we performed Isothermal
Titration Calorimetry (ITC) with H3/H4 using various constructs of JADE1. The ITC data showed
that JADE1(60-104) and JADE1(80-188) bind H3/H4 with comparable dissociation constants of
59.17uM and 52.52uM, respectively (Figure 3.4C), while JADE1 (60-188), containing both
histone binding sites, showed H3/H4 binding with a dissociation constant of about 2-fold higher of
29.41uM (Figure 3.4C). These studies indicate that the HHBD and HCBD regions of JADE1 bind
comparably and additively to H3/H4.
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We also carried out MBP-JADE(1-188) pull down studies with H3/H4 (with or without
tails) in the presence or absence of the HBO-HAT, revealing that the histone binding properties of
JADE1(1-188) are independent of HBO-HAT binding (Figure 3.4D).
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Figure 3. 4The additional JADE1 N-terminal HCBD specifically binds the histone core
region.

(A) MBP-JADE1 pulldowns of four different H3/H4 complexes (H3/H4, H3(TL)/H4, H3/H4(TL),
H3(TL)/H4(TL)) with results resolved on SDS-PAGE. MW Std., molecular weight standard. (B)
GST-H4(1–19) pulldowns of HBO1-HAT in the presence and absence of JADE1(1–188) with
results resolved on SDS-PAGE. (C) ITC studies of JADE1 constructs titrated into the H3/H4
complex showing the heat profile (top) and the calculated binding isotherm (bottom).
Thermodynamic data calculated from these data are shown at the right. (D) MBP-JADE1
pulldowns of HBO1-HAT and H3/H4 complex in the presence and absence of each other, with
results resolved on SDS-PAGE.
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3.3.3 JADE1-HCBD shows selectively for free histone H3/H4 over H2A/H2B and nucleosomes

To further probe the histone binding specificity of JADE1-HCBD, we performed pull down
experiments with MBP-JADE1(1-188) and histones H3/H4 and H2A/H2B. These studies
demonstrated that although JADE1(1-188) interacts with histone H3/H4 in the presence or
absence of the HBO1-HAT, it does not interact with histone H2A/H2B (Figure 3.5A). Moreover, if
we carry out similar pull-down studies with a mixture of H3/H4 and H2A/H2B complexes,
JADE1(1-188) specifically selects for H3/H4 over H2A/H2B, suggesting that JADE1-HCBD does
not interact with the H3/H4 core through a nonspecific charge interaction (Figure 3.5B).

It has been previously demonstrated that the H3 tail is essential for the HBO1-HAT
complex to interact with chromatin(Saksouk et al., 2009). JADE1 contains 2 PHD finger domains
(PHD-Zn knuckle-PHD or PZP domain) C-terminal to the JADE-HCBD that recognize specific
methylation states of the H3 tail and allow the HBO1 HAT complex to bind and acetylate
nucleosomes(Avvakumov et al., 2012; Foy et al., 2008; Saksouk et al., 2009). Given this
information, we wanted to further investigate if the JADE1a -HCBD can bind to H3/H4 when it is
assembled into a nucleosome. Pull-down studies with the assembled nucleosome, revealed the
absence of an interaction (Figure 3.5C), suggesting that the octamer or the DNA is excluding the
JADE1-HCBD binding surface to H3/H4 (Figure 3.5C). To further substantiate these findings, we
compared the acetylation activity of HBO1-HAT and HBO1-FL with or without JADE1(1-188)
against H3/H4 and nucleosomes. These studies revealed that JADE1(1-188) potentiated the
activity of HBO1-HAT and HBO1-FL against H3/H4 but not nucleosomes (Figure 3.5D). This data
suggests that other regions of JADE1 are required for HBO1 targeting to nucleosomes. This is
consistent with previously reported data that the PZP, PHD1 and PHD2 domains of JADE1,
located C-terminal to the JADE1 HHBD and HCBD domains, contribute to HBO1-mediated
acetylation of nucleosomes(Avvakumov et al., 2012; Lalonde et al., 2013; Saksouk et al., 2009).
In contrast, it appears that the HHBD and HCBD domains of JADE1 play an important role in
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capturing free histones (H3/H4) during transcription (or replication) for further acetylation of the
tails.
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Figure 3. 5JADE1 selectively binds to H3/H4 over H2A/H2B and the nucleosome core
particle.
(A) MBP-JADE1 pulldowns of HBO1 HAT and (H3/H4 or H2A/H2B) in the presence or absence of
each other, with results resolved on SDS-PAGE. MW Std., molecular weight standard. (B) MBPJADE1 pulldowns of HBO1 HAT and H3/H4, H2A/H2B and mixtures of the two with results
resolved on SDS-PAGE. (C) MBP-JADE1 pulldowns of H3/H4 or nucleosome core particles with
results resolved on SDS-PAGE. (D) activity comparison of HBO1 HAT and HBO1 full-length in
the presence and absence of a saturating concentration of JADE1(1–188) as either H3H4
complex or nucleosome core particles as the substrate. The activity of these proteins on various
substrates was compared using radioactive counts.
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3.3.4 JADE1-HHBD and JADE1-HCBD bind independently to their respective partners, but
cooperate to potentiate HBO1-HAT acetylation

After establishing that the HHBD and HCBD regions of JADE1 bind independently to their
respective histone and/or HBO1-HAT binding partners, we set out to determine the contribution of
these JADE1 regions for HBO1 acetyltransferase activity. We prepared four JADE1 deletion
constructs spanning the HHBD and/or HCBD regions: 1-188(HHBD-HCBD), 60-188(HHBDHCBD), 80-188(HCBD) and 1-80(HHBD). We assayed HBO1 HAT activity in the presence of 25fold molar excess of each of these JADE1 constructs. This experiment revealed that only a
JADE1 construct spanning both the HHBD and HCBD showed potentiating affects of HBO1-HAT
activity. (Figure 3.6A). Moreover, titration with separate fragments of JADE1 1-80(HHBD) and
JADE1 80-188(HCBD) did not potentiate HBO1-HAT acetylation activity (Figure 3.6A). These
results demonstrate that the JADE1-HHBD and HCBD regions work cooperatively to potentiate
HBO1 HAT activity and that these two regions of JADE1 must be connected to mediate this
activity.

To more quantitatively assess the contribution of JADE1 to HBO1-HAT catalytic activity,
we carried out bisubstrate kinetics. Due to a significant chemical acetylation that occurs on the
core of histones at high concentration, we were not able to carry out a full Michaelis-Menten plot.
Instead, we measured the catalytic efficiency (Kcat/Km) using the slope of the linear range in the
Michaelis-Menten plot. We found that JADE1(1-188) increased the catalytic efficiency of HBO1
by ~5 fold (Figure 3.6B). Together, this data demonstrates the importance of JADE1 in
contributing to the overall catalytic activity of the HBO1 HAT complex by anchoring the complex
to the substrate and by properly orienting the HBO1 HAT domain.
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Figure 3. 6JADE1-HHBD and -HCBD work cooperatively to activate HBO1 HAT activity.

(A) titration of JADE1 constructs (1–188, 60–188, 80–188, 1–80, and 1–80/80–188) from 0 to 25
molar excess over the HBO1 HAT domain tested for acetyltransferase activity on the H3/H4
complex. Radioactive counts are converted to enzyme rate as described under “Experimental
procedures.” B, plot of the linear range of the Michaelis–Menten plot of HBO1-HAT and HBO1-FL
± JADE1 with H3/H4 as the substrate to calculate the catalytic efficiency (slope, Kcat/Km).
Radioactive counts are converted to enzyme rate as described under “Experimental procedures.”
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3.3.5 HBO1 contains a region N-terminal to the HAT domain that binds H3/H4 independent of
JADE1 binding to H3/H4

Having established that the HHBD and HCBD regions of JADE1 contact H3/H4, we
asked if other regions of HBO1 also contribute to histone binding. To address this, we first carried
out pull down studies with MBP-HBO1-HAT, JADE1(80-188) and H3/H4 to demonstrate that the
HBO1-HAT is unable to directly pull down H3/H4 (Figure 3.7A). Although HBO1-HAT does not
make direct contact with histones, we asked if the rest of HBO1 has any contribution toward
H3/H4 binding independent of JADE1. To address this possibility, we carried out H3/H4 pull down
studies with either GST-HBO1-FL or GST alone. This data demonstrated that unlike HBO1-HAT,
HBO1-FL is able to pull down H3/H4 indicating that HBO1 also contains an H3/H4 binding site
outside of the HAT domain independent of JADE1 (Figure 3.7B). Revealing this independent
histone binding property of HBO1-FL, we asked if JADE1 and HBO1 can interact with H3/H4 in
the presence of each other. To do this, we carried out additional MBP-JADE1 pull-down studies
with HBO1-FL and H3/H4 in the presence and absence of JADE1-HHBD. As expected, JADE1(1188) was able to pull down HBO1-FL independent of H3/H4 binding at HCBD. However,
JADE1(108-188) was only able to pull down HBO1-FL in the presence of H3/H4 (Figure 3.7C).
These data suggest two different findings about HBO1 and H3/H4 interaction. First, although
HBO1-HAT only makes JADE1-HHBD dependent contact with H3/H4, HBO1-FL makes JADE1HHBD independent contact with H3/H4. Second, the fact that H3/H4 does not bind to JADE1HCBD or HBO1-FL in a mutually exclusive manner suggests that these 2 proteins bind to H3/H4
at different histone binding sites.

To investigate the role of the additional histone binding domain N-terminal to the HBO1HAT region (HBO1-HBD), we asked if the full length HBO1 shows higher enzymatic efficiency
towards the substrate. When compared, the catalytic efficiencies of HBO-HAT and HBO1-FL are
comparable to each other. This analysis demonstrates that despite the additional histone binding
property of HBO1-FL, HBO1-HBD does not have a significant contribution to the overall HBO1
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catalytic efficiency toward H3/H4 and requires JADE1(1-188) to potentiate its acetyltransferase
activity (Figure 3.6B).

63

Figure 3. 7HBO1-FL contains an N-terminal H3/H4 binding domain that binds histones
independently of JADE1.

(A) MBP-HBO1-HAT pulldown of H3/H4 of H3(TL)/H4(TL) in the presence and absence of
JADE1-HCBD, with results resolved on SDS-PAGE. MW Std., molecular weight standard. (B)
GST-HBO-FL and GST control pulldown of the H3/H4 complex, with results resolved on SDSPAGE. Note that JADE1(80–188) and H3.1 co-migrate on SDS-PAGE. (C) MBP-JADE1(1–188)
and (108–188) pulldown of HBO1-FL ± H3/H4 complex, with results resolved on SDS-PAGE.
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3.3.6 HBO1 may contain an auto-inhibitory domain

We could not detect acetyltransferase activity of full length HBO1 towards H4 peptide
(residues 1-19), while the HBO1 HAT domain contained weak but detectable acetyltransferase
activity towards the same substrate (Figures 3.8). However, when the activity was tested using
the radioactive acetylation assay with the intact H3/H4 heterotetramer as the substrate, both full
length and the HAT domain of HBO1 showed a similar level of activity (Figure 3.6B). In addition,
the pull-down analysis shows that although HBO1 does not make contact with the H4 tail, it does
contact the histone core at the histone core-binding domain(HBD) located outside of the HAT
domain (Figure 3.4B, 3.7B). Together, the data demonstrates that full-length HBO1 only shows
activity toward H4 tail residues in the presence of the histone core or the JADE scaffold protein,
and supports the hypothesis that full-length HBO1 contains an autoinhibitory domain that is
relieved upon histone core domain of JADE domain I binding.
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Figure 3. 8Activity comparison of HBO1 full length vs HBO1 HAT domain

Acetyltransferase activity of HBO full length and the isolated HAT domain in response to titration
of H4 peptide. The output of the assay is displayed as counts per minute (CPM)
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3.3.7 Cellular experiments with JADE1 deletions recapitulate the role of JADE1 in histone and
HBO1 interactions and HBO1 acetyltransferase activity

In order to support the conclusions drawn by the in vitro interaction studies, we performed
co-transfections in HEK 293T cells with vectors expressing different truncation constructs of
JADE1 followed by anti-Flag immunoprecipitation and peptide elution of the complexes. Western
blot analysis of the purified fractions with progressive N-terminal truncations of JADE1 indicates
that deletion of the first 113 amino acids, which includes the HHBD, does not disrupt the
interaction of JADE1 with the HBO1-H3/H4 complex in cells (Figure 3.9A), while the additional
deletion of the JADE1-HCBD abolishes JADE1 interaction with the HBO1-H3/H4 complex, as
reported previously(Avvakumov et al., 2012). The observation that JADE1 constructs that contain
residues C-terminal to the HHBD (53-842, 114-842 and 199-842) immunoprecipitate with
ING4/EAF6 are also consistent with our earlier studies(Avvakumov et al., 2012). We performed a
similar experiment using progressive C-terminal deletions of JADE1, demonstrating that the
region containing the HHBD is also sufficient to interact with HBO1 in cells (Figure 3.9B).

Consistent with the in vitro studies, acetylation assays of cell immunoprecipitated JADE1
deletion constructs demonstrates that acetylation activity requires both the HHBD and HCBD
regions of JADE1 (Figure 3.9C). These results demonstrate that, like observed in vitro, while the
JADE1 HCBD is required to stabilize the HBO1 complex, the JADE1 HHBD region is required to
enable HBO1 acetylation activity towards histones.
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Figure 3. 9JADE1 HHBD and HCBD are both required for HBO1 acetyltransferase activity
on histones in cells.

(A) Western blot (WB) analysis of JADE1 complexes with HBO1, H3, ING4, and EAF6 with
different N-terminal JADE1 truncations. An anti-HA immunoblot was done first to visualize the
HA-tagged subunits of the FLAG-JADE1 complex overexpressed in HEK 293T cells. The
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membrane was then reprobed with the HBO1 antibody (showing endogenous HBO1 association
beside HA-HBO1) and finally with the anti-FLAG antibody. IP, immunoprecipitation; MW Std.,
molecular weight standard. (B) HBO1 association with the C-terminal truncated forms of JADE1.
Anti-HA was followed by anti-FLAG immunoblot on FLAG-JADE1 complex overexpressed in
293T cells (the asterisk denotes the remaining HBO1 HA signal in the anti-FLAG blot). (C) HAT
assay of immunopurified complexes from A. HAT assays were performed on free histones (0.5
μg) with JADE1 complex using the same ratio as for the immunoblotting. Shown is a graphical
representation of counts per minute, measured by scintillation, and a fluorogram of the
radioactive HAT assay on free histones.

3.4 Discussion

Histone tail acetylation events have been linked to many important cellular processes
through controlling chromatin dynamics to mediate various DNA transactions including DNA
replication and gene transcription(Strahl and Allis, 2000; Thomas and Voss, 2007). While the
structure and catalytic activity of HATs have been well delineated, their mode of substratespecific acetylation has been less rigorously analyzed. GCN5 has been reported to mediate
preferential H3K14 acetylation through making extensive direct contact with the residues of the
H3 tail flanking the H3K14 target lysine residue using sequence-based recognition(Rojas et al.,
1999).

On the other hand, numerous HATs function in multi-subunit complexes where the

catalytic efficiency and substrate specificities are determined by subunits outside of the catalytic
domain(Lalonde et al., 2013). A recent structural study on the NuA4 HAT complex revealed a
sequence/position double recognition mechanism for substrate specificity, whereby the HAT
complex binds to the nucleosome through a subunit outside of the catalytic domain to position the
H4 tail proximal to the catalytic domain, which then employs sequence-based recognition for
sequence-specific acetylation(Xu et al., 2016). Additionally, BRFP2 was recently reported to
potentiate and mediate H3 specific acetylation by HBO1 through a short N-terminal fragment that
bridges interaction between the HAT domain and H3/H4(Tao et al., 2017).
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In this chapter, we dissected the role of JADE1 in HBO1 HAT activity toward free
histones (H3/H4) based on previous studies suggesting that JADE1 plays a key role in HBO1
complex H4 substrate specific acetylation. The in vitro and cellular data presented here
demonstrates that robust histone H3/H4 acetylation by the HBO1 requires the HBO1-HAT domain
(residues 311-611), in addition to a 21-residue N-terminal JADE1 region (HHBD, residues 60-80),
which bridges HBO1-HAT and H3/H4, while a second N-terminal JADE1 region (HCBD, residues
108-188) makes additional H3/H4 contacts within the histone core region (Figure 3.10A). The Nterminal region of JADE1 therefore functions as a platform to bring the catalytic HBO1 subunit
and the free histone H3/H4 substrate tail together for catalysis. We also demonstrate that HBO1
may contain an auto-inhibitory function, which is dissipated either by binding to the core domain
of H3/H4 or JADE. We hypothesize that such an auto-inhibitory domain may serve to insure
HBO1 catalytic activity towards cognate histone substrates, over non-histone substrates.

The mechanism of JADE1 activation of the HBO1 HAT complex has similarities and
differences to that of BRFP2. Both JADE1 and BRFP2 contain short N-terminal fragments (HHBD
in the case of JADE1) that bind to both HBO1 and H3/H4, thus bridging appropriate HBO1histone interaction for substrate-specific acetylation. Unlike BRFP2, JADE1 contains a second Nterminal histone binding domain (HCBD) that also binds to H3/H4 and cooperates with the HHBD
to significantly increase the catalytic efficiency of HBO1 for H4 acetylation.

In addition to the role of the N-terminal region of JADE1 in HBO1 acetylation described
here, the role of two C-terminal PHD fingers of JADE1 have previously been characterized.
These tandem PHD fingers cooperate to recognize the H3 tail and facilitate targeting of the HBO1
HAT complex to chromatin for nucleosome binding(Foy et al., 2008). Previous studies have
suggested that the HBO1 HAT complex is heavily localized to transcriptionally active regions
ahead of polymerase to facilitate nucleosome disassembly, consistent with HBO1 complex copurification with the FACT complex(Saksouk et al., 2009). In the context of transcription within
chromatin, JADE1 PHD finger-mediated recognition of methylated histones may facilitate the
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subsequent JADE1 mediated HBO1 acetylation of histone H4 to contribute to nucleosome
disassembly through increasing chromatin dynamics post nucleosome disassembly and/or
provide recognition marks for other proteins involved in transcription elongation. JADE1 has also
been linked to HBO1-mediated histone H4 acetylation during DNA replication(Miotto and Struhl,
2010), although the relative roles of the HHBD, HCBD and other C-terminal JADE1 domains in
this process remains to be determined.
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Figure 3. 10Schematic of the HBO1, JADE1, H3/H4 complex based on the data obtained in
this study.

(A) schematic of the JADE1 and HBO1 domains. (B) schematic of JADE1-HBO1 domain
interactions.
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3.5 Materials and Methods

3.5.1 JADE1/2/3 N-terminal sequence alignment

Sequence alignment for JADE1/2/3 was carried out using ClustalW2(Sievers et al., 2011) and
was further formatted using ESPript (3.0) for more optimal sequence homology of JADE
homologs(Gouet et al., 2003)

3.5.2 Recombinant HBO1 and JADE1 protein production

HBO1 and JADE1 protein constructs were generated by PCR amplification of the corresponding
DNAs, which were cloned into pRSF or pDB.His.MBP vectors using Sacl/NotI sites with a
cleavable N-terminal affinity tags (GST-,6XHIS-,MBP-). These constructs were grown and
expressed using BL21(DE3) cells in LB. Cells were induced for protein overexpression at an OD
~0.6 with 0.5mM IPTG for 16-18 hours at 18 °C. Cells were harvested by centrifugation at 4000
RPM and lysed by sonicating in lysis buffer (20mM Tris(pH 8) 500mM NaCl, 5mM BME, 0.1mg/ml
PMSF). The post lysed sample was spun down at 20,000 RPM for 30 min. and the soluble
fraction of the post-sonicated sample was applied to either, Pierce Glutathione Agarose
resin(Thermo), Amylose resin (NE Biolabs) or Ni-NTA resin (Biosciences) for batch binding at 4°C
for 1 hour. Samples were washed with 20 column volumes (CV) of wash buffer ( 20mM Tris( pH
8), 500mM NaCl, 5mM BME) then eluted with eluant with either 30mM reduced Lglutathione(GST), 20mM maltose monohydrate(MBP), or 300mM Imidazole(6XHIS). Affinity tags
were cleaved with TEV protease or were left on for affinity tag pull-downs. Proteins were further
purified to homogeneity by either HiTrapQ(GE Healthcare) anion exchange column for JADE1
constructs or HiTrapHP(GE Healthcare) cation exchange for HBO1 constructs. Ion exchange
chromatography was performed using a NaCl gradient from 100mM to 1M over 30 CV). To
ensure the proper fold of recombinant proteins, they were subjected to size exclusion
chromatography(SEC) using a Superdex 200 column in 20mM Tris(pH 8), 500mM NaCl, 5 mM
BME. MBP-JADE1(1-188) mutant constructs were generated through site-directed mutagenesis
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using Q5 Hot start polymerase(NEB). All of the mutant constructs were verified by DNA
sequencing and were expressed and purified using the same protocol mentioned previously for
wild-type constructs.

3.5.3 Isothermal Titration Calorimetry

Interaction of HBO1/JADE1 and histone/JADE1 with various JADE1 constructs were
quantitatively analyzed using a MicroCal ITC200(Malvern). All proteins were prepared and
dialyzed to 20mM HEPES (pH 7.5), 500mM NaCl, 5mM BME before the analysis. All ITC
experiments were conducted by injecting 800uM of JADE1 deletion constructs into a calorimetry
cell either containing 40uM of HBO1 HAT of H3/H4. JADE1 deletion constructs were injected in
2uL increments every 2 minutes at 20°C. ITC data were analyzed using MicroCal ITC-ORIGIN
(Malvern).

3.5.4 Histone and nucleosome core particle production

Each of the histones (H3, H4, H2A, H2B) were expressed and purified as inclusion bodies.
Refolding of H2A/H2B, H3/H4 and their purification was performed as previously described(Luger
et al., 1999; Ricketts et al., 2015). Tailless constructs H3(36-135) and H4(20-104) were prepared
the same way as the wild-type. These refolded histone components, in addition to the 601
nucleosome positioning sequence, were used to form nucleosome core particles as previously
described(Luger et al., 1999).

3.5.5 Pull down assay (GST-/MBP-)

2uM of tagged protein with 10uM of untagged protein were incubated together with 50uL of resin
for an hour at 4°C. The reactions were carried out in sizing buffer (20mM Tris(pH 8), 500mM NaCl,
5mM BME). Resin was then washed extensively with the same buffer and was collected for
analysis on SDS-PAGE gel. All of the pull downs were done side by side with the tag alone under
the same conditions as controls for background interactions.
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3.5.6 Histone acetyltransferase(HAT) activity assay

HBO1 HAT activity was measured using a previously described HAT assay with

14C

labeled Ac-

CoA (50-60 mCi/mmol; Moravek)(Yan et al., 2002). A time course for the reaction was initially
performed to determine the linear range of enzyme activity at an enzyme concentration of 200nM
and saturating concentrations of AcCoA (300uM) and H3/H4 (or nucleosome core particles)
(100uM). The HAT reaction was done with 20mM Tris (pH 7.5), 500mM NaCl, 0.25mg/ml BSA for
1 hour at 20°C in a volume of 50uL. The reaction was spotted on P81 filter paper. The positively
charged and C14-labeled H4 peptide portion of the histone complex(H3/H4) was captured on the
filter paper, while free

14C-labeled

Ac-CoA was washed away. The paper was analyzed using

Liquid Scintillation(Berndsen and Denu, 2005). The amount of

14C-labeled

H4 peptide bound to

the paper is directly proportional to the amount of acetyl group transferred from the cofactor to
peptide, thus the data was used to evaluate HBO1 acetyltransferase activity(Berndsen and Denu,
2005). All reactions were done in duplicate. Using the known concentration series of Ac-CoA, a
standard curve was generated. The standard curve was used to convert radioactive counts to
molar units.

3.5.7 JADE1-HBO1 complexes cotransfection in 293T cells

JADE1L, HBO1, hEAF6 and ING4 constructs were generated by PCR amplification of the
corresponding DNAs, which were cloned into pcDNA3 vector encoding a N-terminal Flag tag
using BglII/Xho1 sites or a HA tag. These plasmids were then used to cotransfected 293T cells by
the calcium phosphate method for protein complex overexpression with HA-HBO1/HA-ING4/HAhEAF6 and full length or N-terminal truncated 3xFlag-JADE1L: amino acid 1-842, 53 -842, 114842, 199-842 and 1-113. A second set of cotransfection was done using C-terminal truncated 1x
Flag JADE1: the first 113, 198 or 509 amino acids were overexpressed in combination with HAHBO1. Cells were harvested 48h post-cotransfection and lysed in high salt buffer (450mM NaCl,
50mM Tris-HCl pH 8.0, 1% TX-100, 2mM MgCl2, 0.1mM ZnCl2, 2mM EDTA, 10% glycerol)
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supplemented with protease inhibitor mixture. The NaCl concentration was reduced to 225mM
and the whole cell extract centrifuged at 14,000 RPM for 30 minutes. The Flag JADE1 was purify
from the soluble fraction using anti-Flag M2 affinity beads (Sigma) for 2h at 4°C on rotating wheel.
Flag beads were next washed with the 225mM NaCl buffer and eluted with 400ug/ml of 3X or 1X
Flag peptide (Sigma) for the N-terminal or the C-terminal truncations, respectively.

3.5.8 Immunoblotting

The amount of the different JADE1 construct was normalized empirically following SDS-PAGE
and transfer onto nitrocellulose membrane. Anti-Flag M2 conjugated to horse radish peroxydase
(HRP; Sigma) was used at a 1:10,000 dilution and the immunoblots were visualized using a
Western Lightning plus-ECL reagent (Perkin-Elmer). Anti-HA 3F10 (Roche, rat polyclonal) and
anti-HBO1 (Novus, rabbit polyclonal) antibodies were used at a 1:1,000 dilution. HRP conjugated
secondary anti-rat and anti-rabbit antibodies (Sigma) were used at a 1:10,000 dilution.

3.5.9 HAT activity assays on purified JADE1 complexes

HBO1 activity in the purified JADE1 complexes was measured with 0.125uCi of 3H labeled AcCoA (2.1Ci/mmol; PerkinElmer Life Sciences). The amount of the different purified JADE1
complexes used in the HAT assays were normalized based on the immonublotting data. The HAT
reactions were performed in a volume of 15 or 20ul using 0.5ug of human free histones or native
short oligonucleosomes as substrate, respectively, in HAT buffer (50mM Tris-HCl (pH 8), 50mM
KCl, 10mM sodium butyrate, 5% glycerol, 0.1mM EDTA, 1mM dithiothreitol) for 1 hour at 30°C.
The reactions were then captured on P81 filter paper, the free 3H-labeled Ac-CoA was washed
away and the paper was analyzed using Liquid Scintillation. The 3H counts were used to evaluate
HBO1 acetyltransferase activity in the complexes containing different JADE1 constructs.
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Chapter 4 -Conclusion and Future direction
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4.1 Overview

In this thesis, we identified and characterized the importance of the scaffold protein JADE
in HBO1 HAT activity using biochemical and biophysical analysis. In this chapter we discuss our
findings and possible future directions to further understand the function of the scaffold protein
JADE in the acetyltransferase activity of HBO1.

4.2 JADE as the scaffold protein for the HBO1 HAT complex

Prior to our study, it was known that JADE functions as a platform for other subunits in
the HBO1 HAT complex. However, the actual role of JADE in the acetytranferase activity of
HBO1 was unknown. In this thesis, using a various biochemical and biophysical techniques such
as affinity tag pull-down, radioactive acetylation assay, and ITC we have demonstrated that the
function of an N-terminal region of JADE is to recruit the H3/H4 histone substrate within close
proximity to HBO1 for acetylation. Although our study did not address any potential allosteric
effects of JADE on the HAT domain of HBO1, it remains a distant possibility and further study is
necessary to address this possibility.

Recent crystallographic information for the yeast NuA4 HAT Complex reveals that the
Epl1 scaffold protein contains a loop that is responsible for both binding to the HAT domain of
Esa1 and the nucleosome. The loop functions in two ways, hence the name, dual functional
loop(DFL). First, binding of the DFL to the HAT domain of Esa1 rearranges the active site into a
conformation more suitable for catalysis. Second, adjacent to the HAT binding region in the DFL
is the nucleosome-binding domain, which helps position the NuA4 complex proximal to the
histone H4 tail substrate(Xu et al., 2016). However, a recent crystal structure of the HBO1 HAT
domain in complex with a fragment of BRPF2 reveals that BRPF2 positions the substrate
proximal to the active site without allosterically modulating the active site as observed for the
Esa1/Epl1 complex(Tao et al., 2017). Whether the JADE functions in a manner more akin to Epl1
or BRPF2 remains unclear and requires further investigation.
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4.3 Kinetic approach to understanding the possible allosteric affects of JADE1 on HBO1
HAT domain

In our study, using MBP pull-down and Isothermal titration calorimetry (ITC), we
demonstrated that 2 regions of JADE1(HHBD,HCBD) bind to the core of H3/H4 with different
affinities. In combination with our biochemical data, we hypothesize that the HCBD of JADE1
anchors the HBO1 HAT complex on the histones and the HHBD orients the HAT domain by
acting as a bridge between the HAT domain and the substrate. However, it remains unclear if the
JADE-HHBD has any sort of allosteric effects on the HBO1 catalytic site. Although more
extensive study is necessary to fully confirm, we have some data suggesting a possible allosteric
affect of JADE1 on HBO1. Our biochemical studies in Chapter 3 reveals that both JADE and
HBO1 bind to the core of H3/H4 and neither have additional contact with the H4 tail. Using this
information, we proposed a model where JADE1 acts as a scaffold to mediate the interaction
between the active site and core of the substrate, H3/H4. Our proposed model suggests that the
interaction between JADE and the H3/H4 core locates the H4 tail proximal to the active site of
HBO1, increasing the local concentration of the H4 tail. If this is the only way JADE activates
HBO1, we should not observe JADE stimulating HBO1 activity when the H4(1-19) peptide is used
as substrate. However, the fact that we saw stimulation of HBO1 activity towards the H4 tail
peptide(1-19) in the presence of JADE1 leads us to think that there might be more than just
recruitment of the substrate by binding at the histone core (Figure 2.10).

Although a structure of the HBO1/JADE complex would help fully elucidate any potential
allosteric contributions of JADE, we can learn whether JADE1 has allosteric effects on the HAT
domain through carrying out a series of biochemical assays. To better understand the effect of
the JADE HHBD on the HBO1 HAT domain, we can conduct the previously described radioactive
acetylation assay using various combinations of the histone core and tail as the substrate. Using
the HBO1/JADE1 complex we can test the acetyltransferase activity towards various histone
combinations as the substrate; H3/H4, (TL)H3/(TL)H4/H4 tail, H4 tail. The comparison of the
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kinetic parameters of the HBO1 HAT complex towards these substrates would be a useful tool to
fully understand how JADE1 activates HBO1 for its acetyltransferase activity.

4.4 H3/H4 core chemical acetylation

Using H3/H4 as the substrate we determined the enzymatic rate of different HBO1 HAT
complexes by calculating the initial slope of the Michaelis-Menten model. When we performed the
acetylation assay to understand the kinetics of the HBO1 HAT complex using H3/H4 as the
substrate, we were not able to carry out the full Michaelis-Menten kinetics due to high levels of
chemical acetylation on the core of the histones. Further exploration is necessary to develop an
assay with diminished chemical acetylation. The ability to screen activity of the different HAT
complexes in high concentration of histones will allow us to fully determine the Michaelis-Menten
enzyme kinetics and characterize different histone acetyltransferases complexes.

4.5 Purification of the HBO-HAT holo complex.

Co-infection of the 4 viruses containing FLAG-HBO1, HA-JADE3, HA-Eaf6, and HA-ING4
in Sf9 cells leads to a stable expression of each subunit and formation of a 4-protein complex that
could be purified in solution. However, the final yield of this HAT complex in the was low
(~1mgs/ml). We speculate that these human proteins are very complicated in their biology and
put a lot of stress on our Sf9 expression system as we co-infect 4 different viruses into the same
cell. We need to develop better methods to express and co-purify this 4-protein HAT complex for
further studies. Recently Peters and co-workers developed a method to assemble up to 25 genes
in one expression vector, leading to stable expression and complex formation(Weissmann et al.,
2016). We can utilize this system to clone 4 of these HBO1 HAT complex genes into one
expression vector, which may lead to a more stable complex with higher product yield. The ability
to purify this complex in a high amount will help us to further characterize the activity and
structure of this complex.
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4.6 HBO1 inhibitor development

Because of the link between HBO1 and other MYST HAT proteins to cancer, and
particularly with chromosomal translocations, there has been a significant interest in developing
protein-selective MYST inhibitors(Suzuki and Miyata, 2006; Zheng et al., 2008), but with very
limited success. Zheng and coworkers have developed hTIP60 inhibitors that are competitive with
acetyl-CoA (A-CoA) with IC50 values ranging from 149 µM to 400 µM. These inhibitors bind to the
A-CoA binding pocket of the HAT domain in a manner that is competitive with A-CoA. Although
some inhibitors show better IC50 than the known natural product inhibitor curcumin
(diferuloylmethane), they do not show selectivity amongst different HATs(Wu et al., 2011). In
addition, Zheng and coworkers prepared analogs of the known natural product HAT inhibitor,
anacardic acid, resulting in the identification of a series of 6-alkylsalicylates with selectivity for
MYST proteins over Gcn5 and p300, with the most potent compound competing against A-CoA,
with IC50 values of 74 µM and 47 µM for hTIP60 and hMOF, respectively(Ghizzoni et al., 2012).
Their docking study shows that the most potent inhibitor binds either at the core (A-CoA binding
pocket) or around the MYST domain. Due to the structural homology and similar catalytic
mechanism between different MYST acetyltransferases, it is not a surprise that the IC50 against
different MYST enzymes is comparable. The MYST family HATs function as members of multiprotein complexes, as is true for many other acetyltransferases (Avvakumov et al., 2012). The
various associated subunits of the MYST HAT complex are especially important in catalytic
activities and substrate specificities of these HAT complexes.(Shahbazian and Grunstein, 2007)
This phenomenon opens the possibility of targeting other subunits of the respective MYST HAT
complexes or their interactions with the catalytic subunit to develop MYST selective inhibitors. In
the case of HBO1, targeting JADE or its interaction with HBO1 could be a fruitful avenue of
investigation.
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Appendix A -Biochemical studies on the Nat10 acetyltransferase
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A.1 Abstract

NAT10 has been shown to be a cancer biomarker and the first line of response to
genotoxins. Recently, the inhibition of NAT10 was shown to alleviate LNMA depleted
lamenophetic cells. Using this information, we carried out biochemical studies to understand the
function and inhibition of NAT10.

A.2 Introduction

LMNA, which encodes lamin A and C, has an important function in contributing to the
shape of nuclear lamina and overall organization of chromatin. Mutations in these genes cause
laminopathies, including the accelerated-aging disease Hutchinson-Gilford progeria syndrome
(HGPS) (De Sandre-Giovannoli et al., 2003; Eriksson et al., 2003; Worman and Bonne, 2007).
Proper regulation of lamin A expression is important, as any misregulation of expression or
localization can lead to various cancers (Broers et al., 1993; Galiova et al., 2008; Moss et al.,
1999). As the depletion of LMNA causes defects to the shape of the nuclear lamina leading to
global chromatin relaxation, it was thought that acetylation or deacetylation may play an important
role in improving the nuclear shape through modulating chromatin architecture. For this reason,
Jackson and coworkers included a library of HAT and HDAC inhibitors in screening for small
molecules that alleviated the defects in nuclear shape of the LMNA depleted cells. Using this
method they identified a HAT inhibitor 4-(4-chlorophenyl)-2-(2-cyclopentylidenehydrazinyl). This
molecule showed a restoration of nuclear circularity and global chromatin compaction in siLMNA
cells lacking Lamin A/C. This compound completely rescued nuclear-shaping within 12 hours of
treatment. The fact that the molecule was directly involved in the remodeling the nuclear lamina
resulted in the name Remodelin for this newly identified compound. Using click-chemistry
Jackson and coworkers identified the target for Remodelin as NAT10(Larrieu et al., 2014).
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NAT10 has been previously linked with SUN1 nuclear envelope protein(Chi et al., 2007).
NAT10 has been shown to be co-localized primarily to the cell nucleolus(Liu et al., 2007; Shen et
al., 2009) contributing to overall maintenance of the nuclear shape(Amin et al., 2007; Amin et al.,
2008). In addition, NAT10 expression level increases as a response to genotoxic agents(Liu et al.,
2007). NAT10 was also shown to be a biomarker for cancer as the locallization of NAT10 is highly
correlated with tumor grading(Shen et al., 2009). Using tubulin as a substrate, they showed that
NAT10 harbors acetyltransferase activity towards tubulin and Remodelin was able to show the
same level of inhibition as a catalytic mutant. NAT10 inhibition in laminopathic cells is suggested
to reduce microtubule anchorage, which then releases the external force of the nuclear envelope,
leading to reshaping of the nucleus and improvement in overall health of the cell(Larrieu et al.,
2014). In a recent study, NAT10 was shown to be involved in ribosome biogenesis and rRNA
actylation. In this study, Lafontaine and coworkers proposed a new mechanism that NAT10
inactivation leading to correction of laminopathic cells may be due to reduced ribosome
biogenesis(Sharma et al., 2015).

Although previous studies have identified a small molecule inhibitor that can alleviate
laminopathic cells, the molecular basis of how Remodelin inhibits the acetyltransferase activity of
NAT10 is still unknown. Having this gap in knowledge, we planned to investigate the general
function of NAT10 and use X-crystallography to understand the molecular basis for function and
inhibition of NAT10.

We could then use this knowledge to potentially develop more potent

inhibitor for NAT10 specific diseases.

NAT10 is a very large protein that contains various additional domains such as DUF1725,
ATPase, RNA helicase, and a tRNA binding domain in addition to the acetyltransferase
domain(Larrieu et al., 2014) (Figure A.1A). Other domains of NAT10 have functions outside of
acetylation such as substrate recognition and RNA binding(Sharma et al., 2015).
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A.3 Result

In order to biochemically characterize NAT10, we set out to prepare recombinant protein.
We initially attempted to make the full length NAT10 protein with very limited success. Both
Baculovirus sf9 and E.coli expression systems were not able to produce soluble full length NAT10.
We then tried to make various recombinant constructs of the NAT10 HAT domain using
evolutionary conservation of the acetyltransferase domain to guide construct design (Figure
A.1B). From our construct screening of the HAT domain, we identified a construct of NAT10 (494753) that led to good expression and soluble purification (Figure A.2). The isolated
acetyltransferase domain of NAT10 showed a proper fold.
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Figure A. 1 NAT10

(A)Schematic representation of NAT10 (B) Sequence alignment of the acetyltransferase domain
of different orthologs of NAT10.Larrieu et al, (2014) Science
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Figure A. 2 Purification of NAT10 acetyltransferase domain

(A) S200 size exclusion chromatography run of the isolated acetyltransferase of NAT10 (494-735)
(B) S200 run resolved on SDS-PAGE gel.
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Using this NAT10 fragment, we performed Isothermal titration calorimetry (ITC)
experiments with NAT10 (494-735) and either Acetyl-CoA, Acetonyl-CoA, or CoA. The ITC data
show that NAT10 (494-753) is able to bind to acetyl-CoA, Acetonyl-CoA, and CoA with Kd values
of 5.26uM, 7.04uM, 13.45uM, respectively (Figure Appendix A.3). The fact that acetyl-CoA and
the derivatives stably bound to the HAT domain suggested that the acetyltransferase domain was
properly folded. The previous study by Jackson et al, using a 3D model suggested that
Remodelin may bind to the A-CoA binding pocket of the HAT domain. Taking this information, we
also performed ITC with NAT10 (494-753) and Remodelin (Synthesized by Dr. Jeffrey Winkler’s
laboratory, Department of Chemistry, University of Pennsylvania). From this experiment, we were
not able to detect binding of Remodelin to NAT10 (Figure Appendix A.3.3).

We performed Sypro Orange Thermal Shift assays with NAT10 (494-735) alone and in
the presence of A-CoA and Remodelin (Figure Appendix A.3.4). The apparent melting
temperature of the apo HAT domain was ~42.3C° and the apparent melting temperature of the
acetyltransferase domain in the presence of acetyl-CoA increased by ~8C°. However, in
correlation with the ITC data, Remodelin did not further stabilize the acetyltransferase domain of
NAT10.

Together, this data suggested that Remodelin does not directly bind the

acetyltransferase domain of NAT10 (Figure A.4).

88

Figure A. 3 ITC of NAT10(494-753) with A-CoA, Acetonyl-CoA, CoA, Remodelin
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Figure A. 4 Thermal Shift Assay of NAT10 (494-753) with A-CoA, Remodelin
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After demonstrating that NAT10 (494-753) binds tightly to acetyl-CoA but not to
Remodelin, we tested the ability of the NAT10 acetyltransferase domain to modify the proposed
α-tubulin substrate(Shen et al., 2009). We tested the acetyltransferase activity of the NAT10 HAT
domain against 3 different substrates; microtubules, MAP-enriched tubulin, and α-tubulin. We
monitored NAT10 acetylation using two methods: the previously described radioactivity assay, as
well as western blot with an anti-pan-acetyl antibody to detect the activity of NAT10 at two
different reaction temperatures (Figure A.5,6). However, we were not able to detect activity of
NAT10 with either assays.

A.4 Discussion

Although we were not able to confirm the role of Remodelin in the inhibition of NAT10
activity towards tubulin or microtubules, RNA has more recently been identified as the substrate
for NAT10(Ito et al., 2014). A recent publication indicated that cytidine acetylation by NAT10 was
shown to be critical in riobosome biogenesis. For future studies we plan to investigate the role of
NAT10 in RNA acetylation.
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Figure A. 5 Radioactive assay of NAT10 acetyltransferase activity.

Acetyltransferase activity was measured using Microtubule, MAP enriched tubulin, Tubulin as
substrates. The output of the assay is displayed as counts per minute (CPM) (A) 25C°(B) 37C°
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Figure A. 6Radioactive assay of NAT10 acetyltransferase activity.

Acetyltransferase activity was measured using Microtubule, MAP enriched tubulin, Tubulin as
substrates. The output of the assay was detected using anti-acetyl-lysine antibody. (A) 25C°
(B)37C°
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A.5 Materials and Methods

A.5.1 NAT10 orthologs sequence alignment

Sequence

alignment

for

NAT10

from

different

organisms

was

carried

out

using

ClustalW2(Sievers et al., 2011) and was further formatted using ESPript (3.0) for more optimal
sequence homology of NAT10 orthologs(Gouet et al., 2003)

A.5.2 Recombinant NAT10 protein production

NAT10 protein constructs were generated by PCR amplification of the corresponding DNAs which
were cloned into pDB.His.MBP vectors using Sacl/NotI sites with a cleavable N-terminal affinity
tags (MBP-). These constructs were grown and expressed using BL21(DE3) cells in LB. Cells
were induced for protein overexpression at an OD ~0.6 with 0.5mM IPTG for 16-18 hours at
18 °C. Cells were harvested by centrifugation at 4000 RPM and lysed by sonicating in lysis buffer
(20mM Tris(pH 8) 500mM NaCl, 5mM BME, 0.1mg/ml PMSF). The post lysed sample was spun
down at 20,000 RPM for 30 min. and the soluble fraction of the post-sonicated sample was
applied to Amylose resin (NE Biolabs) for batch binding at 4°C for 1 hour. Samples were washed
with 20 column volumes (CV) of wash buffer ( 20mM Tris( pH 8), 500mM NaCl, 5mM BME) then
eluted with eluant with 20mM maltose monohydrate(MBP). Affinity tag was cleaved with TEV
protease. To ensure the proper fold of recombinant proteins, they were subjected to size
exclusion chromatography(SEC) using a Superdex 200 column in 20mM Tris(pH 8), 500mM NaCl,
5 mM BME.

A.5.3 Tubulin Purification

Tubulin was purified from porcine brain according to Gell et al(Gell et al., 2011). Tubulin was
assembled into microtubule by methods described (Piperno et al., 1987)
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A.5.4 NAT10 Acetylation assays

Acetylation assay on microtubule, tubulin, MAP-enriched tubulin was done as described in the
methods(Friedmann et al., 2012).

95

Reference

Allfrey, V.G., and Mirsky, A.E. (1964). Structural Modifications of Histones and their
Possible Role in the Regulation of RNA Synthesis. Science 144, 559.
Allis, C.D., Berger, S.L., Cote, J., Dent, S., Jenuwien, T., Kouzarides, T., Pillus, L.,
Reinberg, D., Shi, Y., Shiekhattar, R., et al. (2007). New nomenclature for chromatinmodifying enzymes. Cell 131, 633-636.
Amin, M.A., Matsunaga, S., Ma, N., Takata, H., Yokoyama, M., Uchiyama, S., and Fukui,
K. (2007). Fibrillarin, a nucleolar protein, is required for normal nuclear
morphology and cellular growth in HeLa cells. Biochem Biophys Res Commun 360,
320-326.
Amin, M.A., Matsunaga, S., Uchiyama, S., and Fukui, K. (2008). Depletion of
nucleophosmin leads to distortion of nucleolar and nuclear structures in HeLa cells.
Biochem J 415, 345-351.
Avvakumov, N., Lalonde, M.E., Saksouk, N., Paquet, E., Glass, K.C., Landry, A.J., Doyon,
Y., Cayrou, C., Robitaille, G.A., Richard, D.E., et al. (2012). Conserved molecular
interactions within the HBO1 acetyltransferase complexes regulate cell proliferation.
Mol Cell Biol 32, 689-703.
Berndsen, C.E., and Denu, J.M. (2005). Assays for mechanistic investigations of
protein/histone acetyltransferases. Methods 36, 321-331.
Berndsen, C.E., and Denu, J.M. (2008). Catalysis and substrate selection by
histone/protein lysine acetyltransferases. Curr Opin Struct Biol 18, 682-689.
Broers, J.L., Raymond, Y., Rot, M.K., Kuijpers, H., Wagenaar, S.S., and Ramaekers, F.C.
(1993). Nuclear A-type lamins are differentially expressed in human lung cancer
subtypes. The American journal of pathology 143, 211-220.
Brownell, J.E., Zhou, J., Ranalli, T., Kobayashi, R., Edmondson, D.G., Roth, S.Y., and
Allis, C.D. (1996). Tetrahymena histone acetyltransferase A: a homolog to yeast
Gcn5p linking histone acetylation to gene activation. Cell 84, 843-851.
Chi, Y.H., Haller, K., Peloponese, J.M., Jr., and Jeang, K.T. (2007). Histone
acetyltransferase hALP and nuclear membrane protein hsSUN1 function in decondensation of mitotic chromosomes. The Journal of biological chemistry 282,
27447-27458.
De Sandre-Giovannoli, A., Bernard, R., Cau, P., Navarro, C., Amiel, J., Boccaccio, I.,
Lyonnet, S., Stewart, C.L., Munnich, A., Le Merrer, M., et al. (2003). Lamin a
truncation in Hutchinson-Gilford progeria. Science 300, 2055.
Doyon, Y., Cayrou, C., Ullah, M., Landry, A.J., Cote, V., Selleck, W., Lane, W.S., Tan, S.,
Yang, X.J., and Cote, J. (2006). ING tumor suppressor proteins are critical regulators
of chromatin acetylation required for genome expression and perpetuation.
Molecular cell 21, 51-64.
Drazic, A., Myklebust, L.M., Ree, R., and Arnesen, T. (2016). The world of protein
acetylation. Biochim Biophys Acta 1864, 1372-1401.
Drazic, A., and Winter, J. (2014). The physiological role of reversible methionine
oxidation. Biochim Biophys Acta 1844, 1367-1382.
96

Duong, M.T., Akli, S., Macalou, S., Biernacka, A., Debeb, B.G., Yi, M., Hunt, K.K., and
Keyomarsi, K. (2013). Hbo1 is a cyclin E/CDK2 substrate that enriches breast cancer
stem-like cells. Cancer research 73, 5556-5568.
Eriksson, M., Brown, W.T., Gordon, L.B., Glynn, M.W., Singer, J., Scott, L., Erdos, M.R.,
Robbins, C.M., Moses, T.Y., Berglund, P., et al. (2003). Recurrent de novo point
mutations in lamin A cause Hutchinson-Gilford progeria syndrome. Nature 423, 293298.
Feng, Y., Vlassis, A., Roques, C., Lalonde, M.E., Gonzalez-Aguilera, C., Lambert, J.P., Lee,
S.B., Zhao, X., Alabert, C., Johansen, J.V., et al. (2016). BRPF3-HBO1 regulates
replication origin activation and histone H3K14 acetylation. The EMBO journal 35,
176-192.
Foy, R.L., Song, I.Y., Chitalia, V.C., Cohen, H.T., Saksouk, N., Cayrou, C., Vaziri, C., Cote,
J., and Panchenko, M.V. (2008). Role of Jade-1 in the histone acetyltransferase (HAT)
HBO1 complex. The Journal of biological chemistry 283, 28817-28826.
Friedmann, D.R., Aguilar, A., Fan, J., Nachury, M.V., and Marmorstein, R. (2012).
Structure of the alpha-tubulin acetyltransferase, alphaTAT1, and implications for
tubulin-specific acetylation. Proc Natl Acad Sci U S A 109, 19655-19660.
Galiova, G., Bartova, E., Raska, I., Krejci, J., and Kozubek, S. (2008). Chromatin
changes induced by lamin A/C deficiency and the histone deacetylase inhibitor
trichostatin A. Eur J Cell Biol 87, 291-303.
Gell, C., Friel, C.T., Borgonovo, B., Drechsel, D.N., Hyman, A.A., and Howard, J. (2011).
Purification of tubulin from porcine brain. Methods Mol Biol 777, 15-28.
Ghizzoni, M., Wu, J., Gao, T., Haisma, H.J., Dekker, F.J., and George Zheng, Y. (2012). 6alkylsalicylates are selective Tip60 inhibitors and target the acetyl-CoA binding site.
Eur J Med Chem 47, 337-344.
Gouet, P., Robert, X., and Courcelle, E. (2003). ESPript/ENDscript: Extracting and
rendering sequence and 3D information from atomic structures of proteins. Nucleic
acids research 31, 3320-3323.
Haberland, M., Johnson, A., Mokalled, M.H., Montgomery, R.L., and Olson, E.N.
(2009a). Genetic dissection of histone deacetylase requirement in tumor cells. Proc
Natl Acad Sci U S A 106, 7751-7755.
Haberland, M., Montgomery, R.L., and Olson, E.N. (2009b). The many roles of histone
deacetylases in development and physiology: implications for disease and therapy.
Nat Rev Genet 10, 32-42.
Havasi, A., Haegele, J.A., Gall, J.M., Blackmon, S., Ichimura, T., Bonegio, R.G., and
Panchenko, M.V. (2013). Histone acetyl transferase (HAT) HBO1 and JADE1 in
epithelial cell regeneration. The American journal of pathology 182, 152-162.
Iizuka, M., and Stillman, B. (1999). Histone acetyltransferase HBO1 interacts with
the ORC1 subunit of the human initiator protein. The Journal of biological chemistry
274, 23027-23034.
Iizuka, M., Takahashi, Y., Mizzen, C.A., Cook, R.G., Fujita, M., Allis, C.D., Frierson, H.F.,
Jr., Fukusato, T., and Smith, M.M. (2009). Histone acetyltransferase Hbo1: catalytic
activity, cellular abundance, and links to primary cancers. Gene 436, 108-114.
97

Ito, S., Horikawa, S., Suzuki, T., Kawauchi, H., Tanaka, Y., Suzuki, T., and Suzuki, T.
(2014). Human NAT10 is an ATP-dependent RNA acetyltransferase responsible for
N4-acetylcytidine formation in 18 S ribosomal RNA (rRNA). The Journal of biological
chemistry 289, 35724-35730.
Jenuwein, T., and Allis, C.D. (2001). Translating the histone code. Science 293, 10741080.
Jones, D.T. (1999). Protein secondary structure prediction based on position-specific
scoring matrices. J Mol Biol 292, 195-202.
Kornberg, R.D. (1974). Chromatin structure: a repeating unit of histones and DNA.
Science 184, 868-871.
Kornberg, R.D., and Lorch, Y. (1999). Twenty-five years of the nucleosome,
fundamental particle of the eukaryote chromosome. Cell 98, 285-294.
Kueh, A.J., Dixon, M.P., Voss, A.K., and Thomas, T. (2011). HBO1 is required for
H3K14 acetylation and normal transcriptional activity during embryonic
development. Molecular and cellular biology 31, 845-860.
Lalonde, M.E., Avvakumov, N., Glass, K.C., Joncas, F.H., Saksouk, N., Holliday, M.,
Paquet, E., Yan, K., Tong, Q., Klein, B.J., et al. (2013). Exchange of associated factors
directs a switch in HBO1 acetyltransferase histone tail specificity. Genes &
development 27, 2009-2024.
Lalonde, M.E., Cheng, X., and Cote, J. (2014). Histone target selection within
chromatin: an exemplary case of teamwork. Genes & development 28, 1029-1041.
Larrieu, D., Britton, S., Demir, M., Rodriguez, R., and Jackson, S.P. (2014). Chemical
inhibition of NAT10 corrects defects of laminopathic cells. Science 344, 527-532.
Liu, H., Ling, Y., Gong, Y., Sun, Y., Hou, L., and Zhang, B. (2007). DNA damage induces
N-acetyltransferase NAT10 gene expression through transcriptional activation. Mol
Cell Biochem 300, 249-258.
Luger, K., Rechsteiner, T.J., and Richmond, T.J. (1999). Preparation of nucleosome
core particle from recombinant histones. Methods in enzymology 304, 3-19.
Marmorstein, R., and Zhou, M.M. (2014). Writers and readers of histone acetylation:
structure, mechanism, and inhibition. Cold Spring Harb Perspect Biol 6, a018762.
Miotto, B., and Struhl, K. (2008). HBO1 histone acetylase is a coactivator of the
replication licensing factor Cdt1. Genes & development 22, 2633-2638.
Miotto, B., and Struhl, K. (2010). HBO1 histone acetylase activity is essential for DNA
replication licensing and inhibited by Geminin. Molecular cell 37, 57-66.
Moss, S.F., Krivosheyev, V., de Souza, A., Chin, K., Gaetz, H.P., Chaudhary, N., Worman,
H.J., and Holt, P.R. (1999). Decreased and aberrant nuclear lamin expression in
gastrointestinal tract neoplasms. Gut 45, 723-729.
Peterson, C.L., and Laniel, M.A. (2004). Histones and histone modifications. Curr Biol
14, R546-551.
Piche, B., and Li, G. (2010). Inhibitor of growth tumor suppressors in cancer
progression. Cell Mol Life Sci 67, 1987-1999.
Piperno, G., LeDizet, M., and Chang, X.J. (1987). Microtubules containing acetylated
alpha-tubulin in mammalian cells in culture. J Cell Biol 104, 289-302.
98

Ricketts, M.D., Frederick, B., Hoff, H., Tang, Y., Schultz, D.C., Singh Rai, T., Grazia
Vizioli, M., Adams, P.D., and Marmorstein, R. (2015). Ubinuclein-1 confers histone
H3.3-specific-binding by the HIRA histone chaperone complex. Nature
communications 6, 7711.
Rojas, J.R., Trievel, R.C., Zhou, J., Mo, Y., Li, X., Berger, S.L., Allis, C.D., and Marmorstein,
R. (1999). Structure of Tetrahymena GCN5 bound to coenzyme A and a histone H3
peptide. Nature 401, 93-98.
Saha, R.N., and Pahan, K. (2006). HATs and HDACs in neurodegeneration: a tale of
disconcerted acetylation homeostasis. Cell Death Differ 13, 539-550.
Saksouk, N., Avvakumov, N., Champagne, K.S., Hung, T., Doyon, Y., Cayrou, C., Paquet,
E., Ullah, M., Landry, A.J., Cote, V., et al. (2009). HBO1 HAT complexes target
chromatin throughout gene coding regions via multiple PHD finger interactions with
histone H3 tail. Molecular cell 33, 257-265.
Sapountzi, V., and Cote, J. (2011). MYST-family histone acetyltransferases: beyond
chromatin. Cell Mol Life Sci 68, 1147-1156.
Shahbazian, M.D., and Grunstein, M. (2007). Functions of site-specific histone
acetylation and deacetylation. Annual review of biochemistry 76, 75-100.
Sharma, S., Langhendries, J.L., Watzinger, P., Kotter, P., Entian, K.D., and Lafontaine,
D.L. (2015). Yeast Kre33 and human NAT10 are conserved 18S rRNA cytosine
acetyltransferases that modify tRNAs assisted by the adaptor Tan1/THUMPD1.
Nucleic acids research 43, 2242-2258.
Shen, Q., Zheng, X., McNutt, M.A., Guang, L., Sun, Y., Wang, J., Gong, Y., Hou, L., and
Zhang, B. (2009). NAT10, a nucleolar protein, localizes to the midbody and regulates
cytokinesis and acetylation of microtubules. Exp Cell Res 315, 1653-1667.
Sievers, F., Wilm, A., Dineen, D., Gibson, T.J., Karplus, K., Li, W., Lopez, R., McWilliam,
H., Remmert, M., Soding, J., et al. (2011). Fast, scalable generation of high-quality
protein multiple sequence alignments using Clustal Omega. Molecular systems
biology 7, 539.
Smith, E.R., Eisen, A., Gu, W., Sattah, M., Pannuti, A., Zhou, J., Cook, R.G., Lucchesi, J.C.,
and Allis, C.D. (1998). ESA1 is a histone acetyltransferase that is essential for growth
in yeast. Proc Natl Acad Sci U S A 95, 3561-3565.
Strahl, B.D., and Allis, C.D. (2000). The language of covalent histone modifications.
Nature 403, 41-45.
Struhl, K. (1998). Histone acetylation and transcriptional regulatory mechanisms.
Genes & development 12, 599-606.
Suzuki, T., and Miyata, N. (2006). Epigenetic control using natural products and
synthetic molecules. Curr Med Chem 13, 935-958.
Tao, Y., Zhong, C., Zhu, J., Xu, S., and Ding, J. (2017). Structural and mechanistic
insights into regulation of HBO1 histone acetyltransferase activity by BRPF2.
Nucleic acids research 45, 5707-5719.
Taverna, S.D., Li, H., Ruthenburg, A.J., Allis, C.D., and Patel, D.J. (2007). How
chromatin-binding modules interpret histone modifications: lessons from
professional pocket pickers. Nat Struct Mol Biol 14, 1025-1040.
99

Thomas, T., and Voss, A.K. (2007). The diverse biological roles of MYST histone
acetyltransferase family proteins. Cell cycle 6, 696-704.
Turner, B.M. (2000). Histone acetylation and an epigenetic code. Bioessays 22, 836845.
Verdin, E., and Ott, M. (2015). 50 years of protein acetylation: from gene regulation
to epigenetics, metabolism and beyond. Nat Rev Mol Cell Biol 16, 258-264.
Weissmann, F., Petzold, G., VanderLinden, R., Huis In 't Veld, P.J., Brown, N.G.,
Lampert, F., Westermann, S., Stark, H., Schulman, B.A., and Peters, J.M. (2016).
biGBac enables rapid gene assembly for the expression of large multisubunit protein
complexes. Proc Natl Acad Sci U S A 113, E2564-2569.
Worman, H.J., and Bonne, G. (2007). "Laminopathies": a wide spectrum of human
diseases. Exp Cell Res 313, 2121-2133.
Wu, J., Wang, J., Li, M., Yang, Y., Wang, B., and Zheng, Y.G. (2011). Small molecule
inhibitors of histone acetyltransferase Tip60. Bioorg Chem 39, 53-58.
Xu, P., Li, C., Chen, Z., Jiang, S., Fan, S., Wang, J., Dai, J., Zhu, P., and Chen, Z. (2016).
The NuA4 Core Complex Acetylates Nucleosomal Histone H4 through a Double
Recognition Mechanism. Molecular cell 63, 965-975.
Yan, Y., Barlev, N.A., Haley, R.H., Berger, S.L., and Marmorstein, R. (2000). Crystal
structure of yeast Esa1 suggests a unified mechanism for catalysis and substrate
binding by histone acetyltransferases. Molecular cell 6, 1195-1205.
Yan, Y., Harper, S., Speicher, D.W., and Marmorstein, R. (2002). The catalytic
mechanism of the ESA1 histone acetyltransferase involves a self-acetylated
intermediate. Nature structural biology 9, 862-869.
Ythier, D., Larrieu, D., Brambilla, C., Brambilla, E., and Pedeux, R. (2008). The new
tumor suppressor genes ING: genomic structure and status in cancer. International
journal of cancer 123, 1483-1490.
Zheng, Y.G., Wu, J., Chen, Z., and Goodman, M. (2008). Chemical regulation of
epigenetic modifications: opportunities for new cancer therapy. Med Res Rev 28,
645-687.
Zhou, M.I., Wang, H., Ross, J.J., Kuzmin, I., Xu, C., and Cohen, H.T. (2002). The von
Hippel-Lindau tumor suppressor stabilizes novel plant homeodomain protein Jade-1.
The Journal of biological chemistry 277, 39887-39898.

100

